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GENERAL INTRODUCTION 
This study contains clinical, electrophysiologic, morphologic and bio­
chemical investigations in children with the cerebro-hepato-renal syn­
drome (CHR-S) of Zellweger. In the first chapter the present knowledge 
about peroxisomes is presented. This is required to understand the in­
vestigations reported in Chapter IV, V and VI. Chapter II reviews the 
literature on the Zellweger syndrome. Special attention is also given 
to data referring to clinically and/or biochemically related disorders. 
Chapter III and IV give a survey of clinical symptoms, relevant labora­
tory findings and neurophysiological data from our patients. As the neo­
natal form of adrenoleukodystrophy (ALD) has a clinical and biochemical 
resemblance to CHR-S, the adrenocortical function -disturbed in ALD- was 
tested in CHR-S (Chapter V). The very long chain fatty acids measured 
in cultured skin fibroblasts of CHR-S patients demonstrated a constant 
increased concentration of С.,
 η
 (Chapter VI). This finding offers the 
possibility of antenatal diagnosis (Chapter VI and VIII). 
Pipecolic acid (PA) level in serum and urine, the first reported bioche­
mical abnormality in CHR-S, remains a valuable tool for the confirmation 
of the clinical diagnosis of CHR-S, when gestational age and age after 
birth are taken into consideration (Chapter VII). 
15 

CHAPTER I 
PEROXISOMES IN MAMMALS AND IN MAN 
INTRODUCTION 
Microbodies were first described in the proximal tubular epithelium of 
mouse kidney by Rhodin in 1954 and by Rouiller and Bernhard in hepatic 
parenchymal cells in 1956. They are now considered as ubiquitous subcel­
lular organelles in eukaryotic cells. The term microbody is only a mor­
phological description and includes also a percentage of quite unrelated 
structures such as the hydrogenosome in Trichomonas and the glycosome in 
protozoan blood parasites. De Duve and Baudhuin, 1966, who developed 
procedures for isolating microbodies, introduced the name peroxisomes, 
for cellular organelles characterized by their content of catalase and 
several oxidative enzymes. The function of peroxisomes involves the 
production and degradation of hydrogen peroxide. The peroxisomes are a 
subgroup of the microbodies. They should be distinguished from glyoxyso-
mes present e.g. in Tetrahymena, the latter containing in addition at 
least malate synthetase and isocitrate lyase allowing the functioning of 
the glyoxylate cycle (De Duve, 1983) . We will limit this short review to 
the peroxisomes of mammals. 
MORPHOLOGY 
Peroxisomes are particles ranging in diameter from 0.1 to 1.5 μπι (avera­
ge about 0.5 um)· The limiting membrane is a single membrane consisting 
of a triple layered structure. The membrane is thinner than that of ly-
sosomes and plasma membrane. The peroxisomal membrane is highly permea­
ble to small molecules such as sucrose and hydrogen peroxide. Freeze-
fracture replicas of hepatic peroxisomes reveal numerous particles (7-8 
nm) often in clusters, on the protoplasmic face of the limiting membra­
ne, whereas the extracellular face is almost devoid of such particles 
(Reddy et al, 1974). The matrix has a granular appearance. An electron-
dense core (nucleoid), in which a series of parallel membranes or latti­
ce structure can be observed, is present In the peroxisomes of many ani­
mal species. The presence of nucleoids is, in most cases, closely rela­
ted to the occurrence of urate oxidase. The most readily recognizable 
peroxisomes are those localized in liver and kidney cells. 
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In addition to the peroxisomes with the characteristics just described, 
a population of smaller "microperoxisomes" has been described in mamma­
lian cells. These microperoxisomes are roughly circular, elongate in 
shape with a diameter of 0.15-0.25 μιη and lack a central core. They seem 
to have frequent continuities of their delimiting membrane with that of 
the endoplasmic reticulum (ER). They contain catalase while urate oxida­
se is lacking. The microperoxisomes are widely distributed among mamma­
lian tissues (Masters and Holmes, 1977, Novikoff and Novikoff, 1982). 
BIOGENESIS OF PEROXISOMES 
Several models of peroxisome biogenesis have been proposed. In the clas­
sical model peroxisomal proteins are synthesized on bound ribosomes and 
channelled through the ER to the growing peroxisomes, budding outgrowths 
of the ER, which pinch off (De Duve and Baudhuin, 1966). 
This model has been severely criticized by Lazarow et al (1982). After 
pulse-labeling of a rat, radioactive catalase was not found in microso­
mal vesicles. Catalase mRNA was not located on bound polysomes. They 
proposed an alternative model. The peroxisomal proteins are synthesized 
on free polysomes and enter preexisting peroxisomes post-translationally 
from the cell sap; new peroxisomes are thought to be formed by fission 
from preexisting ones. Their hypothesis is supported by impressive ex­
perimental evidence. They could prove that the proteins were indeed syn­
thesized on free polysomes at their mature size rather than as large 
precursors both in vivo and in vitro. 
Fuijke et al (1982) were able to isolate highly purified peroxisomes, 
mitochondria and rough and smooth microsomes of rat liver. The polypep­
tide composition of the peroxisomal membrane is very different from that 
of the ER or mitochondrial membrane, proving that the peroxisomal mem­
brane is not simple an expansion of the membrane of the ER. The main 
phospholipids (phosphatidylcholine and phosphatidylethanolamine) are 
similar in the three membranes. In contrast to the mitochondria, peroxi­
somal membranes contain no cardiolipin. Crane et al (1982) found a dif­
ferent relative phospholipid composition in the peroxisomal, microsomal 
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and mitochondrial fraction of mouse liver. The closest similarity in 
phospholipid composition was between the microsomal and peroxisomal 
fraction. Lazarow et al (1982) suggested that newly synthesized consti-
tuents (from cytosol?, from ER?) are incorporated into the preexisting 
membrane and then further distributed by fission and fusion events. 
On the basis of their experiments in mouse liver. Masters (1982) propo-
sed a modification of the theory of Lazarow. In mouse liver catalase 
exists in five electrophoretic different forms. In the peroxisome cata-
lase is present as the anodic form, whereas in the cytosol catalase is 
represented by the more cathodic forms. The cathodic forms show a pro-
gressive desialation. Masters' working model is represented in Fig. 1. 
According to this scheme he still accepts that the peroxisomal membrane 
originates from ER. Newly synthesized catalase apomonomer interacts with 
receptors on the membrane of the nascent peroxisomes. The hemegroup is 
inserted and the tetramer form of the enzyme assembled. Sialation of the 
enzyme takes place. A decreasing degree of association of the active en-
zyme with the peroxisomal membrane is observed with aging of the peroxi-
some. Eventual degradation of the peroxisome occurs and catalase is re-
leased into the cytosol. The cytosol catalase is desialated and heme de-
graded. The "aged" form of catalase stimulates peroxisomal biogenesis. 
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Fig. 1: A working model of peroxisomal biogenesis and turnover 
(according to Masters, 1982). 
3 
4,5 
aged catalase binds to receptors on specialized areas of 
the ER. 
newly synthesized catalase apoprotein is inserted into the 
nascent peroxisome and assembled into the active enzyme. 
catalase activity in membrane associated form. 
catalase converted to a loosely associated form. 
oc oc Pool 
\ 
Degradation of Aged Enzyme. 
Synthesis and Insertion -
Final 
Catalase 
Degradation 
E.P.C. 
hJ ot New Catalase by Nascent 
Peroxisome 
Membrane 
Bound 
Catalase 
(5) Ί 4 ) 
'Final Peroxisomal Degradation 
• = catalase activity in membrane associated f o r m . 
о = catalase converted to a loosely associated f o r m . 
u = aged catalase 
P. D.E. = peroxisomal detergent extract. 
P.A.E. = peroxisomal aqueous e x t r a c t . 
E.P.C. = e x t r a particulate cytoplasmic catalase. 
Permission granted by the New York Academy of Sciences . 
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CYTOCHEMISTRY 
Several cytocheraical staining procedures to localize enzyme activities 
within peroxisomes are reported (Tolbert and Essner, 1981). The most 
widely used method is the diaminobenzidine (DAB) procedure originally 
described by Graham and Karnovsky (1966). It is assumed that catalase, 
acting peroxidatively, oxidizes the DAB to a congregated double-bond 
structure that binds large amounts of glutaraldehyde and appears opaque 
by electron microscopy. A selective staining of peroxisomes is possible 
(Angermüller and Fahimi, 1983). 
In recent years, immunochemical procedures have attained considerable 
importance in the localization of proteins because of their high speci-
ficity. By the protein Α-gold immunochemical procedure Bendayan et al 
(1982, 1983) were able to localize catalase and heat-labile enoyl-CoA 
hydratase, the second (3-oxidation spiral enzyme, in the peroxisomal ma­
trix. The peroxisomal localization of catalase and acyl-CoA oxidase, the 
first oxidative step of the cyanide-Insensitive ß-oxidation, has also 
been studied using monospecific Fab fragments labelled with horseradish 
peroxidase (Yokata and Fahimi, 1981, 1982). 
ENZYMATIC COMPOSITION AND METABOLIC PATHWAYS 
Many of the enzymes found in the peroxisomal compartment occur in other 
compartments of the cell. This review is restricted to a consideration 
of the most characteristic peroxisomal enzymes. In Table 1 the enzymes 
localized in peroxisomes are presented. 
Catalase 
The association of hydrogen peroxide-producing oxidases with catalase is 
a constant metabolic feature of peroxisomes. The substrates of this oxi-
dative capacity include amino acids (D and L ) , hydroxyacids and fatty 
acids. 
Catalase contains 4 heme groups. It consists of four identical subunits 
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with a molecular weight of approximately 60,000. In the reaction mecha­
nism for catalase (Fig. 2), a stable complex of catalase and Η,,Ο» is 
first formed; it then reacts with either another molecule of H„0 or 
R'H„. The stable complex has been monitored in vivo by Chance et al 
(1979) via its characteristic absorption spectrum. 
Recent studies indicate that glutathione peroxidase is of minor impor­
tance relative to that of catalase for the catabolism of H„0 in peroxi­
somes but of major importance in the ER (Jones et al, 1981). 
Fig. 2: The peroxisomal respiratory pathway. 
Η-,Ο-
O, 
2^- ^¿—»·2Η20 
^ г ^ oxidase ^ - - » Η 2 θ 2 catalase 
RH,' R R ' H 2 ~ ^ - 2 H 2 0 
catalatic activity 
peroxidatic activity 
23 
Table 1: Enzymes localized in peroxisomes of mammals. 
Catalase 
Glutathione peroxidase (Jones et al, 
ot-hydroxy acid oxidase 
D-amino acid oxidase 
Urate oxidase 
Hydroxypyruvate/glyoxylate reductase 
1981) 
Glyoxylate aminotransferases e.g. alanine 
&-oxidation of fatty acids: acyl-CoA 
acyl-CoA 
synthetase 
oxidase 
enoyl-CoA hydratase 
3-hydroxyacyl-CoA dehydrogenase 
3-ketoacyl-CoA thlolase (Hashimoto, 1982) 
2,4-dienoyl-CoA reductase (Dommes et 
Carnitine acetyl transferase 
Carnitine octanyl transferase 
al, 1981) 
Acyl-CoA:DHAP acyl transferase (Jones and Hajra, 
Alkyl DHAP synthetase 
Acyl/alkyl DHAP:NADPH oxidoreductase (Hajra and I 
Acyl-CoA-NADPH oxidoreductase (long chain alcohol 
Glycerol phosphate dehydrogenase 
Conversion of THCA into cholic acid 
Glutaryl-CoA oxidase (Vamecq and van 
Polyamineoxidase (Hölttä, 1977) 
Cytochrome c-reductase (Donaldson et 
Gustafsson, 
Hoof, 1984) 
al, 1972) 
1977) 
ishop, 1982) 
forming) 
1980) 
Adaptation of Table 1 of Masters and Holmes (1977). 
New literature is added. 
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L-o-hydroxy acid oxidase and D-amino acid oxidase 
L-a-hydroxy acid oxidase is a flavoprotein that catalyzes the oxidation 
of L-o-hydroxy acids to produce the corresponding α-keto acids and H-0-. 
This enzyme exists as two isozymic forms in mammalian tissue. It cataly­
zes also the oxidative deamination of L-amino acids. 
R R 
I I 
CHOH + O, • C=0 + Η,Ο, 
I I 
COO" COO" 
L - a - h y d r o x y acid • oxygen • a - k e t o - a c i d • hydrogen peroxide 
D-amino acid oxidase i s a f l avoprote in, with FAD as p r o s t h e t i c group, 
which ca ta lyzes the oxidat ive deamination of D-amino a c i d s . The enzyme 
i s l o c a l i z e d in both the cytosol and peroxisomes. 
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Glyoxylate metabolism and aminotransferases 
Although microbodies in different life forms may be morphologically 
similar to animal peroxisomes, they may contain a far greater diversity 
of enzymes. In leaf peroxisomes glycolate produced by photosynthesis is 
oxidized to glyoxylate, which is converted to glycine (Tolbert and Ess-
ner, 1981). 
Hydroxy-pyruvate/glyoxylate reductase and several glyoxylate aminotrans-
ferases (glutamate, serine, histidine, alanine, phenylalanine) are pre-
sent in rat liver peroxisomes. 
CH, 
I 
CH-NH, 
I 2 
COOH 
alanine 
H 
I 
c=o 
I 
COOH 
glyoxylate *= 
CH, 
I 
C=0 
I 
COOH 
=k pyruvate 
H 
I 
CH-NH, 
I 2 
COOH 
glycine 
Takada and Noguchi (1982) have extensively studied the enzyme alanine-
glyoxylate aminotransferase (AGT) in different mammalian species. Mamma-
lian liver contains two forms of the enzyme, designated AGT. and AGT-, 
respectively. AGT has a molecular weight of approximately 80,000 and 
has also serine-pyruvate aminotransferase activity. It is localized in 
the peroxisomes in human, monkey, rabbit and guinea pig, in the mito-
chondria in dog and cat, and in both organelles in rat, mouse and ham-
ster and is not detected in pig and bovine liver. AGT. has a molecular 
weight of approximately 200,000, is found only in mitochondria and has 
no serine-pyruvate aminotransferase activity. This study clearly indica-
tes that it is not possible to infer the subcellular distribution of an 
enzyme in a species, from experiments in another species. 
Urate oxidase 
This enzyme catalyzes the oxidation of urate with molecular oxygen re-
sulting in the formation of allantoine. It is present in the liver of 
many mammalian species but it is absent in microperoxisomes and in man. 
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Although the occurrence of nucleoids in peroxisomes is mostly related to 
the presence of urate oxidase, an exception is known. In man, lacking 
this enzyme, the liver is devoid of nucleoids but the kidney exhibits 
some nucleoid structures (Masters and Holmes, 1977). 
Fatty acid B-oxidation 
ß-oxidation was thought to occur only in the mitochondrial matrix until 
Lazarow and De Duve (1976) proved the presence of a ß-oxidation system 
in rat liver peroxisomes. The reaction-scheme can be seen in Fig. 3. The 
peroxisomal system generates acetyl-CoA through the successive steps of 
oxidation, hydration, dehydrogenation and thiolytic cleavage (Lazarow, 
1982, De Beer and Mannaerts, 1983). The enzymes catalyzing these reac-
tions have been purified and characterized especially by Hashimoto 
(1982) and are different from their mitochondrial counterparts. 
Acyl-CoA synthetase activity is present on the cytosolic side of the 
peroxisomal membrane indicating that acyl-CoA and not the free acid 
crosses the peroxisomal membrane. Carnitine is not required for this 
transport. A fatty acid binding protein could be responsible for a car-
rier process (Appelkvist and Dallner, 1980). The first enzyme of the 
ß-oxidation system is not an acyl-CoA dehydrogenase but an acyl-CoA oxi-
dase and generates H.O-, The enoyl-CoA hydratase and 3-hydroxy-acyl-CoA 
dehydrogenase reside in a single bifunctional protein. 
Hayashi et al (1981) could localize the different enzymes of the ß-oxi-
dation in rat liver peroxisomes. Thiolase is localized in the matrix, 
enoyl-CoA hydratase and 3-hydroxy-acyl-CoA dehydrogenase in the core and 
at least part of acyl-CoA oxidase is weakly associated with the core. 
Peroxisomes are not active against fatty acids shorter than octanoic 
acid (Lazarow, 1978). Fatty acids are thus not completely degraded to 
acetyl-CoA. 
Peroxisomal ß-oxidation is free of respiratory control. The energy of 
the desaturation is not used for ATP formation but is dissipated as heat 
and contributes to thermogenesis. The peroxisomal ß-oxidation system is 
insensitive to KCN or other inhibitors of mitochondrial electron trans-
port when assayed in vitro in broken cell systems and in the presence of 
excess NAD and CoA. 
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The quantitative importance of the peroxisomal ß-oxidation is not exact-
ly known. It is considered to contribute maximally 10% to the overall 
hepatic oxidation of the important fatty acids palmitate and oleate. The 
very long chain fatty acids (>C22) are poorly oxidized by mitochondria 
and it has been proposed that they are shortened in peroxisomes and then 
further oxidized in mitochondria. 
The peroxisomal ß-oxidation seems particularly well suited for the oxi-
dation of long chain mono-unsaturated fatty acids (Osmundsen and Neat, 
1979). Unsaturated fatty acids just as saturated ones are oxidized by 
ß-oxidation but additional enzymes are necessary to eliminate the inter-
fering cis-double bonds. The peroxisomes possess the required enzymatic 
apparatus (Dommes et al, 1981). Dicarboxylic acids are also substrates 
for the peroxisomal ß-oxidation (Mortensen et al, 1982). 
Fig. 3: Fatty acid ß-oxidation sequence in rat liver mitochondria and 
peroxisomes (according to Thomas, 1979). 
? ~ 3 · 
3 - ® * 
rcsp - a ^ c y 
rhdir 
н
г
о ^ o 2 
respiratory 
cha π 
н2о i o , 
MITOCHOND 
R CH; СИ 
Mavoprotein —^ 
- liavoprotem Н
г
+~' 
RIAL SYSTEM PEROXISOMAL SYSTEM 
CO SCoA f a ' t y a c y C o A R CH2-CH2-CO-SCoA 
|dehyd'-ogenase| | oxidase | 
-^ f lavoprotem • - ^ 
^ flavoprotein H 2 - ^ 
R-CH = CH-CO-SCoA ? unsaturate atylCoA R-CH-CH-CO-SCoA 
н
г
о-> 
1 hydratJse 1 
s-нр 
R-CHOt-l-CH2-CO-SCoA 3 hydroxy acylCoA R ОЮН CH2 CO SCoA 
NAD'-*. 
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]dehydrogenase | 
^ - - N A D * 
^ • N A D H * H * 
R-CO-CH2-CO-SCoA 3 oxy асу CoA R-CO-CH2-CO-SCoA 
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|cátaiase| 
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Glycerolipid biosynthesis 
Dihydroxy-acetone-phosphate (DHAP) is known to be the precursor of gly-
cerolipids containing an ether bond. This compound combines with acyl-
CoA to 1-acyl-DHAP (Fig. 4). Via an exchange reaction between the acyl 
group and a long chain alcohol, 1-alkyl-DHAP (containing the ether link) 
is formed, which is converted in the presence of NADPH to 1-alkylglyce-
rol-3-P. After acylation in the 2 position, the resulting l-alkyl-2-
acylglycerol-3-P is hydrolyzed to give the free glycerol derivative, 
which reacts with either CDP-choline or CDP-ethanolamine to form 1-al-
kyl, 2-acylglycerol 3-phosphoethanolamine. 
Fig. 4: Biosynthesis of ether lipids and plasmalogens. 
A C Y L - C O A 9 R , - ( C H , ) , OH N A D P H . H* N A D P * 
4?COH V H j C - O - C - R , г H j C - 0 ( C H , ) 7 - R , 1 • Η 2 Γ Ο ( Γ Η , ) , R ? 
0 = C ^ » Q - C — ^ .. Ю С ^ ' » H O - C H 
1
 - •=·
 Λ Γ ν ι Ί
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г
С О ® * Hf О-© 
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Plasmalogens are formed by desaturation of the glycerol ether lipid. 
Hajra and Bishop (1982) extensively studied the localization of diffe­
rent enzymes involved in the biosynthesis of plasmalogens. In normal rat 
liver DHAP-acyltransferase is mainly localized in peroxisomes while al-
kyl-DHAP-synthase and acyl/alkyl-DHAP-NADPH oxidoreductase had a bimodal 
distribution pattern between peroxisomes and microsomes. In contrast to 
the rat aIky1-DHAP-synthase in the guinea pig liver is present mostly in 
the peroxisomal fraction. 
Several hypotheses about the role of this pathway in peroxisomes are 
proposed. It is possible that acyl-DHAP may participate in transporting 
long chain acyl groups across the peroxisomal membrane (Fig. 5). In this 
scheme, proposed by Hajra and Bishop (1982), the reducing equivalence of 
NADH generated inside the peroxisomes can be carried to mitochondria. 
It is possible to attribute an important role of this pathway in membra­
ne lipid biogenesis e.g. by supplying lipid precursors such as acyl-DHAP 
or alkyl-DHAP to ER. This is an important new field of research. 
Fig. 5: Possible roles of acyl-DHAP in transporting acyl groups and re­
ducing equivalents across the peroxisomal membrane (according 
to Hajra and Bishop, 1982). 
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Bile acid synthesis 
THCA and DHCA are precursors of cholic and chenodeoxycholic acid (Fig. 
6). Pedersen and Gustafsson (1980) found the highest activity for the 
conversion of THCA to cholic acid in a peroxisomal enriched fraction. 
In a more detailed study (Kase' et al, 1983) they could conclude that rat 
liver peroxisomes contain enzymes able to catalyze the cleavage of the 
side chain of THCA. The enzymes involved could be similar but not neces-
sarily identical with those responsible for 0-oxidation of fatty acids. 
Fig. 6: Pathways of cholic acid and chenodeoxycholic acid synthesis 
(according to Danielsson and Sjövall, 1975). 
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DEVELOPMENTAL CHANGES 
The ontogeny of mouse liver peroxisomal enzymes demonstrates coordinated 
increases in catalase, L-a-hydroxy acid oxidase and urate oxidase acti-
vities during the first week of neonatal period. The number of peroxi-
somes increases also rapidly (Masters and Holmes, 1977). 
Development of peroxisomes in rat liver and kidney and mouse kidney has 
also been studied. There is an increase in peroxisomal synthesis and 
enzyme activity predominantly at birth and during the early neonatal 
period (Masters and Holmes, 1977). Developmental changes in peroxisomal 
fatty acid oxidation system have recently been reported in rat liver 
(Krahling et al, 1979, Horie et al, 1981). 
31 
PEROXISOMES AND METABOLIC DISEASES IN MAN 
Introduction 
When microscopic and cytochemical studies of peroxisomes are reported in 
metabolic disorders, it is important to keep in mind the normal varia-
tion and also abnormalities found in different liver diseases. Various 
pathologic processes involving the hepatic cytoplasm exert different 
effects on peroxisomes (Sternlieb and Quintana, 1977). Peroxisomes were 
more abundant and often concentrated in a perinuclear configuration in 
cholestatic and cirrhotic liver. Decreased peroxisomal staining was com-
mon in cholestasis, cirrhosis, hepatitis and in almost all patients with 
malignancies (Roels et al, 1983). 
Acatalasemia (McKusick *20020) 
This disorder was discovered in 1948 by Takahara in a patient with ulce-
rating gangrenous lesions of the oral cavity. Addition of H.O. to 
the operative site did not result in the usual bubbles. It is proposed 
that H_0. produced by bacteria and not decomposed by catalase, oxidizes 
hemoglobin, deprives the infected area of oxygen and causes ulceration. 
There is an almost complete hereditary deficiency of erythrocyte catala-
se. Not enough information is available about residual catalase activity 
in tissues. The catalase activity of fibroblasts cultured from Japanese 
patients was 2 - 4 percent and from Swiss patients approximately 15 per-
cent of the activity found in normals. At least five different classes 
of mutant enzymes can be distinguished in different families indicating 
considerable genetic heterogeneity. 
Cerebrotendinous xanthomatosis (CTX) (McKusick 21370) 
CTX is a rare familial disorder characterized by progressive neurologic 
dysfunction (dementia, spinal cord paresis and cerebellar ataxia), 
tendon xanthomas, cataract and premature atherosclerosis due to deposi-
tion of cholesterol and cholestanol in many tissues. 
According to Goldfischer (1982) a peroxisomal defect may be of pathoge-
netic significance in CTX. An increase in the number and size of peroxi-
somes was observed. In other patients with CTX hepatocellular peroxiso-
mes contained greatly increased matrix density and crystalline inclu-
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slons. Oftebro et al (1980) demonstrated a defect in mitochondrial 26-
hydroxylation in a patient with CTX. Studies in subcellular fractions 
are required before this disease should be included under the head of 
peroxisomal disorders. 
Adrenoleukodystrophy (ALD) 
Adrenoleukodystrophy is a genetically determined disorder affecting the 
white matter of the CNS and the adrenal cortex. Four clinical forms of 
ALD can be distinguished: the childhood form (McKusick *30010), adreno-
myeloneuropathy, the symptomatic heterozygote of childhood ALD and the 
neonatal form (McKusick 20237). It is an X-linked disorder with the ex-
ception of the neonatal form whose inheritance is autosomal recessive. 
The different clinical forms are associated with the accumulation of 
saturated very long chain fatty acids (mainly C-, _, C_. _ and C-, -.). 
These patients have a defect in the oxidation of the very long chain 
fatty acids (C.,- and longer) (Singh et al, 1984). It is accepted that 
this defect may be localized in the peroxisomes (Singh et al, 1984). The 
relation between the neonatal form of ALD and Zellweger syndrome will be 
extensively discussed in the general discussion. 
The cerebro-hepato-renal syndrome of Zellweger (McKusick *21410) 
This syndrome is reviewed in the next chapter. 
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CHAPTER II 
THE CEREBRO-HEPATO-RENAL SYNDROME 
OF ZELLWEGER 
INTRODUCTION 
This chapter gives a survey of the literature on the cerebro-hepato- re-
nal syndrome (CHR-S) of Zellweger. Clinically and/or biochemically simi-
lar disorders (hyperpipecolic acidemia, trihydroxycoprostanic acidemia 
and neonatal adrenoleukodystrophy) are also presented in this chapter. 
The following aspects of the syndrome will be covered: history, clinical 
symptoms, pathologic findings and biochemical abnormalities. 
HISTORICAL SURVEY 
In 1964 Bowen, Lee, Zellweger and Lindenberg described "a familial syn-
drome of multiple congenital defects" in two pairs of sibs (3 girls and 
1 boy), one from a Caucasian family and one from a Negro family, both 
without consanguinity. The prenatal history and delivery were unremarka-
ble. Hypotonia and congenital anomalies (high forehead, frontal bossing, 
large fontanels, epicanthal folds, abnormal ears, simian creases, camp-
todactyly, hypospady, clitoris hypertrophy) were noted at birth. The 
children were unable to suck or swallow. Periods of respiratory dis-
tress, retardation and sudden death occurring before one year of age 
were reported. 
Pathologic findings in the central nervous system (CNS) were described 
in 3 patients: hypoplasia of the cerebellar hemispheres and partial age-
nesis of the corpus callosum in each patient, and absent olfactory bulbs 
in one out of two examined patients. Histopathologic studies of the 
brains revealed nests of ectopic nerve cells in "some areas of the cere-
bral cortex, particularly the insula". 
Pneumonia and/or atelectasis was present in every patient, anomalous ve-
nous return in two out of three infants (one patient with a communica-
tion between the left subclavian vein and the left atrium and one infant 
with the right pulmonary vein entering the right atrium). Multiple sub-
capsular cysts of both kidneys were mentioned in one infant. 
Autosomal recessive inheritance was assumed. 
Unaware of Bowen et al (1964), Smith et al (1965) reported the same 
disease in 1965 as a "newly recognized syndrome". Subsequently approxi-
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mately 90 cases of the disorder have been reported (Table I). Our pa-
tients are reported in Table II (Govaerts et al, 1982). Since 1982, se-
ven new patients have been diagnosed in our department. The case reports 
mentioned 9 sibs with a similar clinical history without further de-
tails. They have been omitted from Table I. On some patients no clinical 
information is available, and these also have been omitted from Table I 
(Goldfischer et al, 1972, 1973B, Lott et al, 1979, Hanson et al, 1979, 
Chalmers et al, 1980, (Endres et al, 1981, Kelley, 1983, Mooi et al, 
1983, Björkhem et al, 1984, Moser et al, 1984). 
A recent review about CHR-S was written by Kelley (1983). 
NOMENCLATURE AND CLASSIFICATION 
The descriptive term "cerebro-hepato-renal syndrome" was first used in 
1967 by Passarge and McAdams. "Zellweger syndrome" was first reported by 
Opitz et al in 1969. The editor of Birth Defects suggested the designa-
tion "the cerebro-hepato-renal syndrome of Zellweger", analogous to "the 
oculo-cerebro-renal syndrome of Lowe" (1969). 
An "undetected inborn error of metabolism" was first suggested by Pas-
sarge and McAdams, 1967. The suggestion of a "neurometabolic defect, 
possibly in the aminoacid metabolism" was made by Kohn and Mündel in 
1969, because of the resemblance of the neuropathologic findings to tho-
se of maple sirup urine disease. 
Evidence for an inborn error of metabolism in this syndrome has been ob-
tained by the establishment of various biochemical abnormalities: iron 
overloading, (Vitale et al, 1969), a "fault in pipecolic acid metabolism 
" (Danks et al, 1975, Trijbels et al, 1979), a defect of bile acid syn-
thesis (Hanson et al, 1979, Monnens et al, 1980), an increased excretion 
of p-OH-phenyllactate in urine (Chalmers et al, 1980, Govaerts et al, 
1982), elevated levels of saturated very long chain fatty acids in fi-
broblasts (Brown et al, 1982) and serum (Bakkeren et al, 1984), defi-
ciency of plasmalogens in tissues (Heymans et al, 1983 and 1984), defi-
ciency of acyl-CoA: DHAP acyltransferase in liver, brain and cultured 
skin fibroblasts (Schutgens et al, 1984). A review of the various bio-
chemical abnormalities is given in Table IV. 
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Studies involving mitochondrial and/or peroxisomal dysfunction or absen­
ce in Zellweger syndrome were published by Goldfischer et al, 1972, 
1973A, 1973В, 1979, 1981, 1982, and 1983, Pfeifer and Sandhage, 1979, 
Müller-Höcker et al, 1981 and 1984, Borchard et al, 1982, Sarnat et al, 
1983, Trijbels et al, 1979 and 1983, Borst, 1983. The term "peroxisomes 
deficiency" was proposed by Pfeifer and Sandhage, 1979, as a name that 
probably was more closely related to the pathogenetic mechanism than the 
usual designation cerebro-hepato-renal syndrome. 
Nevertheless, in many handbooks and textbooks this condition is described 
in the group of structural (brain) defects (Smith, 1982, Swaiman and 
Wright, 1982, Nelson, 1983), although the term "inborn error(s) of 
metabolism" is always noted. 
THE CLINICAL MANIFESTATIONS OF ZELLWEGER SYNDROME 
Clinical signs 
The clinical manifestations are summarized in Table IX. 
Pictures of these infants are given in Chapter III. The CHR-S has been 
reported in several races. Mostly the Caucasian race was noted, occa-
sionally other races were described: Negro family (Bowen et al, 1964), 
Jewish family (Kohn and Mündel, 1969), Indian parents (Poznanski et al, 
1970), Mexican parents (Williams et al 1972), Pakistani family (Garner 
et al, 1982). 
The gestational period and delivery were usually unremarkable. Two mo-
thers noticed a poor activity of their baby during pregnancy (Opitz et 
al, 1969, Sommer et al, 1974). Breech presentation was mentioned in 5 
out of 112 patients (patients 7, 10, 11, 18, 95 from Table I). Caesarian 
section was performed in 4 cases (patients 15, 73, 96, from Table I and 
patient 12 from Table II). Vertex delivery was reported in the other 
children. The prominent signs at birth were "mongoloid" appearance with 
large fontanels and hypotonia. One of our patients presented with the 
clinical picture of cholestatic icterus; laparotomy was performed. 
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When the children survived the first weeks of life psychomotor retarda-
tion, seizures, ocular involvement and hearing impairment were frequent-
ly noted. Feeding difficulties were nearly always present. In 55 out of 
90 patients surviving for more than two weeks, failure to thrive was 
reported despite a normal intake of calories by tube feeding. 
Age at death and cause of death 
Within the group of patients there is a marked variation in the age at 
death. Most children died within the first year of life, but some pa-
tients survived for several years (see Tables I and II and Fig. 1). The 
cause of death is given in Tables I, II and III. Respiratory failure or 
arrest and sudden death occurred in 35 out of 71 patients. 
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TABLE I: Patients with the cerebro-hepato-renal syndrome of Zellweger 
reported in the literature. 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
Author 
В owe η 
Bowen 
Bowen 
Bowen 
Smith 
Smith 
Passarge 
Passarge 
Passarge 
Passarge 
Passarge 
Punnett 
Vitale 
Vitale 
Kohn 
Kohn 
Opitz 
Opitz 
Opitz 
Opitz 
Taylor 
Jan 
Jan 
Poznanski 
Poznanski 
Poznanski 
Patton 
Patton 
Williams 
Williams 
Stanescu 
Volpe 
Year 
1964 
1964 
1964 
1964 
1965 
1965 
1967 
1967 
1967 
1967 
1967 
1968 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1970 
1970 
1970 
1970 
1970 
1972 
1972 
1972 
1972 
1972 
1972 
Sex 
M 
F 
F 
F 
M 
F 
F 
F 
F 
F 
F 
M 
F 
M 
F 
F 
F 
F 
F 
M 
M 
F 
F 
F 
F 
F 
F 
F 
M 
M 
F 
F 
Age at death 
3 
5 
5 
3 
2 
10 
6 
1 
2 
Ih 
5 
9 
ih 
6 
17 
2 
25 
7 
23 
5 
20 
1 
24 
3 
2 
12 
18 
4 
64 
5 
9 
4 
d 
m 
m 
m 
m 
w 
m 
m 
w 
m 
h 
m 
m 
m 
d 
m 
h 
m 
d 
ш 
d 
m 
d 
m 
m 
d 
w 
m 
m 
m 
m 
Cause of death 
not mentioned 
sudden death 
sudden death 
sudden death 
\ icterus 
(distended abdomen, intestinal 
) haemorrhages 
congestive heart failure 
respiratory failure 
respiratory failure 
not mentioned 
not mentioned 
pneumonia 
pneumonia 
respiratory failure 
pneumonia 
not mentioned 
respiratory failure 
respiratory failure 
pneumonia? 
respiratory arrest 
respiratory arrest 
sudden death 
sudden death 
respiratory arrest 
not mentioned 
respiratory arrest 
pneumonia 
pneumonia 
not mentioned 
not mentioned 
not mentioned 
sudden death 
44 
Case 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Author 
Gotero 
Vincens 
Goldfischer 
Goldfischer 
S опте г 
Sommer 
Sommer 
Sommer 
Garzuly 
Bernstein 
Bernstein 
Bernstein 
Gómez 
Danks 
Danks 
Danks 
Danks 
Danks 
Danks 
Danks 
Danks 
Variend 
Agamanolis 
Haddad 
Liu 
Escorihuela 
de León 
de león 
Camera 
Brun 
Brun 
Carlson 
Evrard 
Year 
1973 
1973 
1973 
1973 
1974 
1974 
1974 
1974 
1974 
1974 
1974 
1974 
1974 
1975 
1975 
1975 
1975 
1975 
1975 
1975 
1975 
1976 
1976 
1976 
1976 
1976 
1977 
1977 
1977 
1978 
1978 
1978 
1978 
Sex 
M 
F 
M 
F 
M 
F 
M 
F 
M 
M 
F 
M 
M 
F 
F 
M 
M 
M 
M 
F 
F 
F 
M 
? 
M 
M 
M 
M 
F 
M 
F 
M 
M 
Age at 
5 
4 
7 
6 
18 
18 
1 
23 
4 
? 
? 
? 
5 
15 
6 
9 
3 
2 
9 
8 
2 
7 
4 
4 
54 
13 
3 
8 
10 
14 
14 
16 
5 
death 
w 
m 
w 
w 
d 
d 
d 
d 
m 
m 
w 
w 
w 
w 
w 
d 
w 
d 
d 
m 
d 
m 
d 
m 
m 
w 
w 
w 
w 
w 
Cause of death 
pneumonia 
respiratory failure 
not mentioned 
not mentioned 
not mentioned 
pneumonia 
not mentioned 
pneumonia 
not mentioned 
pneumonia 
pneumonia 
respiratory failure 
pneumonia 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
pneumonia 
respiratory failure 
congestive heart failure 
respiratory failure 
respiratory failure 
not mentioned 
pneumonia 
pneumonia 
respiratory arrest 
respiratory arrest 
pneumonia 
not mentioned 
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Case 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
Author 
Bartoletti 
Bartoletti 
Bartoletti 
Bartoletti 
Agamanolis 
Parmentier 
Pfeifer 
Friedman 
Mathis 
Mathis 
Hong 
Müller-Höcker 
Kretzer 
Della Giustina 
Della Giustina 
Hittner 
Hittner 
Hittner 
Hittner 
Toussaint 
Borchard 
Borchard 
Borchard 
Garner 
Sarnat 
Sarnat 
Sarnat 
Sarnat 
Gustafsson 
Gustafsson 
Müller-Höcker 
Year 
1978 
1978 
1978 
1978 
1979 
1979 
1979 
1980 
1980 
1980 
1981 
1981 
1981 
1981 
1981 
1981 
1981 
1981 
1981 
1981 
1982 
1982 
1982 
1982 
1983 
1983 
1983 
1983 
1983 
1983 
1984 
Sex 
M 
M 
F 
M 
M 
F 
F 
M 
M 
M 
M 
F 
M 
M 
F 
M 
F 
F 
F 
F 
F 
F 
M 
F 
F 
F 
F 
M 
M 
F 
F 
Age at 
3 
1 
2 
2h 
4 
2 
14 
3 
44 
5 
6 
7 
3 
6 
12 
7 
2h 
eh 
ioh 
7 
16 
15 
6 
13 
44 
1 
4 
11 
2 
3 
7 
death 
d 
d 
ш 
У 
m 
m 
У 
m 
m 
m 
m 
w 
m 
d 
d 
m 
m 
m 
w 
d 
m 
m 
w 
m 
m 
m 
m 
m 
w 
w 
Cause of death 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
congestive heart failure 
pneumonia 
pneumonia 
pneumonia 
respiratory failure 
not mentioned 
pneumonia 
pneumonia 
respiratory failure 
respiratory failure 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
heart failure 
not mentioned 
not mentioned 
not mentioned 
pneumonia 
respiratory failure 
not mentioned 
not mentioned 
respiratory failure 
marasm 
marasm 
respiratory failure 
M - male y » year( s ) d = day(s) 
F = female m « month(s) h = hour(s) 
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TABLE II: Our patients (present situation). 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Author 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Govaerts 
Year 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
1982 
Sex 
F 
M 
M 
M 
F 
M 
M 
M 
M 
M 
M 
F 
M 
M 
M 
M 
Age at death 
54 m 
5 m 
7 m 
1 w 
5 w 
6 ш 
510/12 y 
born in 1977 
29/12 y 
5 w 
48/12 y 
born in 1980 
1 m 
3 m 
2 m 
born in 1981 
Cause of death 
pneumonia 
pneumonia 
pneumonia 
sudden death 
pneumonia 
sudden death 
sudden death 
alive 
pneumonia 
sudden death 
sudden death ? 
alive 
pneumonia 
sudden death 
sudden death 
alive 
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TABLE III: Cause of death in patients with cerebro-hepato-renal syndrome 
of Zellweger. 
Cause of death 
cardio-resplratory problem 
- pneumonia 
- respiratory failure or arrest 
- congestive heart failure or arrest 
sudden death 
intestinal haemorrhages 
шагает 
not mentioned 
Number 
54 
28 
22 
4 
13 
2 
2 
38 
N = 109 
3 patients are still alive (born 08/06/1977, 08/01/1980, 28/11/1981). 
Fig. 1: Age at death of patients suffering from the Zellweger syndrome. 
N = 104, the age was not mentioned in 5 patients, 3 patients are 
still alive. 
number • 
6 0
n 
50-
40-
30-
20-
io-
52 31 10 1 1 
1^=0 I I"1 
0-3 3-6 6-9 9-12 1-2 2-3 3-4 4-5 5-6 
age months years 
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Heredity 
The cerebro-hepato-renal syndrome is inherited as an autosomal recessive 
trait. In McKusick's "Mendelian Inheritance in Man" the disorder is men-
tioned as *21410. 
In twenty out of the eighty families two or more affected children are 
reported. In nine other families biochemical or pathologic findings we-
re mentioned in nine sibs with similar clinical history without further 
description. Consanguinity is known in 13 families. 
It is not possible to quote the number of normal sibs in the families; 
generally only the affected sibs were mentioned. In the group of pa-
tients where the sex is known 55 of them are boys and 56 girls (see 
Tables I and II). 
These data on the family history of patients, and the distribution of 
sex are in accordance with an autosomal recessive inheritance pattern. 
Biochemical investigations reported by Bakkeren et al, 1984, Heymans et 
al, 1984 and Schutgens et al, 1984, confirm this mode of inheritance. No 
structural chromosomal abnormalities have been described. 
The incidence of this syndrome is estimated to be approximately 1 in 
100,000 births in Australia (Danks et al, 1975). In the Netherlands, ba-
sed on the number of known patients, about the same incidence is found. 
ROENTGENOLOGIC AND ELECTROPHYSIOLOGIC STUDIES 
Roentgenologic studies 
Roentgenologic abnormalities were mentioned in the first description of 
the cerebro-hepato-renal syndrome by Bowen et al, 1964: calcific densi-
ties overlying the ischium and hip joints bilaterally and in relation to 
the cervical spine, the epiphyses of the hands and calcific stippling of 
the patellae (patient 2). This abnormal calcification of the patellae is 
the most conspicuous roentgenologic feature of the Zellweger syndrome 
(30 out of 37 patients). Punctate calcifications were described in seve-
ral bones: os occipitale (1 patient), hyoid bone (2 patients), thyroid 
cartilages (2 patients), sternum (2 patients), scapula (2 patients), 
proximal humeral epiphysis (3 patients), radius and ulna (1 patient), 
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spine (3 patients), costovertebral articulations (1 patient), acetabulum 
(6 patients), hip joint (5 patients), inferior pubic ramus (1 patient), 
upper femoral epiphysis (4 patients), distal femoral epiphysis (4 pa-
tients) , tibial epiphysis (1 patient). It is interesting to note that 
occasionally the diagnosis was first suggested in the radiology depart-
ment (Bartoletti et al, 1978). 
A number of authors mentioned retarded bone age (8 patients ). Occasio-
nally osseous demineralization was reported (2 patients). Six patients 
with a normal skeletal survey were noted. 
No consistent abnormalities were found by I.V.P. Cystic changes of the 
kidneys were suggested by ultrasonography of 3 patients (Garner et al, 
1982, Sarnat et al, 1983). 
Computer tomography and/or pneumoencephalography revealed a slight dila-
tation of the ventricles. Cerebral arteriography was not mentioned in 
the literature. 
Electrophysiologic studies 
Electrophysiologic studies were only rarely mentioned: 
26 EEC's, 11 EMG's, 8 ERG's, 6 VEP's, no BAEP's or SSEP's. 
In 3 patients a normal EEG was noted although clinical seizure activity 
was present. The other EEC's were abnormal, mostly epileptiform activity 
was seen. High voltage and slow wave activity in the occipital area and 
vertex was reported by Agamanolis and Patre, 1979, and Mathis et al, 
1980. 
The EMG's were always normal: the motor conduction velocity was normal, 
no signs of denervation were present. 
ERG examination revealed normal retinal signs once (Volpe and Adams, 
1972); an extinguished ERG was found by the other authors. The VEP's 
were seriously disturbed or could not be recorded. Garner et al (1982) 
reported failure of normal maturation and deterioration of the VEP in 
one patient. 
The electrophysiologic data of our patients are described in Chapter IV. 
50 
HISTOPATHOLOGIC STUDIES 
Central nervous system (65 patients) 
Macroscopic studies. 
Macroscopic studies of the CNS in the cerebro-hepato-renal syndrome of 
Zellweger showed consistent alterations. Most conspicuous findings were 
generalized polymicrogyration and corpus callosum hypoplasia (Gilchrist 
et al 1976, Evrard et al, 1978, Friedman et al, 1980). Frequently dila-
tation of the cerebral ventricles and olivary dysplasia were observed 
(Gilchrist et al, 1976, Evrard et al, 1978, Friedman et al, 1980). 
Occasionally data concerning the olfactory bulbs and optic nerves were 
given; in 6 out of 10 patients hypoplasia was noted (Opitz et al, 1969, 
Volpe and Adams, 1972, Variend et al, 1976, de León et al, 1977, 
Toussaint et al, 1981). 
Dysmyellnatlon was a constant finding (Gilchrist et al, 1976, Evrard et 
al, 1978, Friedman et al, 1980). No macroscopic abnormalities in spinal 
cord structure were recorded (Agamanolis and Patre, 1979). 
Microscopic studies. 
The neuropathology showed a striking similarity, with only quantitative 
differences. 
Cytoarchitectonic abnormalities with neuronal heterotopia and dysmyell-
natlon were constant findings (Passarge and McAdams, 1967, Opitz et al, 
1969, Volpe and Adams, 1972, Garzuly et al, 1974, Agamanolis et al, 1976 
and 1979, Liu et al, 1976, de León et al, 1977, Brun et al, 1978, Evrard 
et al, 1978). These changes were described as most pronounced in the ce-
rebral cortex; they were also common in the cerebellum, the brain stem 
and the spinal cord. Heterotopic Purkinje cells in the white matter of 
the cerebellar folia and lack of convolution of the dentate nuclei were 
reported by Volpe and Adams, 1972 and Evrard et al, 1978. Retarded cel-
lular differentiation was mentioned by Brun et al, 1978 and Garner et 
al, 1981. 
The inferior olivary nuclei were markedly abnormal with laminar discon-
tinuities in the principal nucleus (Evrard et al, 1978). Agamanolis and 
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Pâtre, 1979, reported ectopic large motor neurons in the subpial white 
matter of the spinal cord and chromatolysis and vacuolization of many 
neurons in the dorsal nuclei of Clarke. 
In contrast to the striking disturbance of the cortex, the architecture 
of the deep nuclear structures was normal (Volpe and Adams, 1972, Agama-
nolis and Patre, 1979). It should be noted that nearly every patient 
showed subependymal periventricular cysts (Brun et al, 1978). 
PAS-positive, diastase negative granules in cortical neurons, which were 
more abundant in the areas of polymicrogyria, were described by Agamano-
lis and Patre (1979). 
Diffuse accumulation of sudanophilic, Sharlach R, oil red 0 and Sudan 
Black В positive and PAS-negative, non-metachromatic droplets within 
glial cells and histiocytes scattered in the cortex was frequently des­
cribed (Passarge and McAdams, 1967, Agamanolis et al, 1976, Liu et al, 
1976, de León et al, 1977, Brun et al, 1978, Evrard et al, 1978). 
Peculiar multinucleated "globoid" cells with partly strongly sudanophi-
lic cytoplasm and partly PAS-positive granules were reported by de León 
et al, 1977 and Agamanolis and Patre, 1979. Lipid-loaden histiocytes we-
re found in periventricular white matter (Volpe and Adams, 1972, Agama-
nolis and Patre, 1979). Swollen astrocytes with faintly eosinophilic cy-
toplasm and neurons with ballooned perikaryon were reported by de León 
et al (1977). 
Biochemical studies of brain lipids in one patient revealed an extraor-
dinary increase (14% compared to a normal value of 0.5%) of a neutral 
lipid, identified as a cholesterol ester by thin-layer and gas chromato-
graphy, which is the oil red 0-stained material (Goldfischer et al, 
1973A). "Siderosis" was mentioned in three out of 65 patients. 
The decreased volume of white matter, compared with age-matched con-
trols, is probably caused by hypomyelination and demyelination. Paucity 
of Oligodendroglia cells, which produce myelin, was noted by Opitz et 
al, 1969, and Brun et al, 1978. A destructive process is strongly sug-
gested by the gliosis and the lipid-loaden histiocytes and globoid cells 
(Agamanolis et al, 1976). 
52 
Electron microscopie studies. 
Electron microscopie studies on central nervous system tissue from pa-
tients with the CHR-S of Zellweger were performed by Goldfischer et al 
(1972 and 1973A), Agamanolis et al (1976, 1979), Liu et al (1976), de 
León et al (1977) and Brun et al (1978). The autolytic changes of the 
brain tissue made accurate account of the ultrastructural details diffi-
cult; only Goldfischer et al (1972 and 1973A) reported ultrastructural 
studies on brain biopsy tissue. 
Goldfischer et al, 1972 and 1973A, payed attention to the structure and 
function of the mitochondria in CHR-S. Dense matrices and slightly dila-
tated intracristal spaces were described in the mitochondria of the CNS. 
Peroxisomes couldn't be found in cortical astrocytes. 
On electronmicroscopic examination, the PAS-positive material in neuro-
nal cytoplasm was composed of closely packed, uniform particles, with an 
о 
average diameter of 300 A, identical in all respects with glycogen g-
particles (Agamanolis and Patre, 1979). Rarely, small coherent clusters 
or rosettes corresponding to α-particles were seen in the cytoplasm of 
neuroglial cells and of nerve cells. In a few instances, the glycogen-
filled cells contained also dense or membranous lipid bodies. No other 
ultrastructural studies reported glycogen accumulation in CNS tissues. 
The content of the lipid-filled cells consisted of multilamellar myelin 
bodies and rarely membrane-bound, moderately dense, globular lipid ag­
gregates (Agamanolis et al, 1976 and 1979, Liu et al, 1976). Longitudi­
nal or slightly curved fiber-like electron-lucent structures, measuring 
90 A, and clusters of short, 250 to 3Ö0 A thick, needle- or cleft-like 
lucent spaces were visualized. Some lipid bodies contained sligthly cur-
o о 
ved tubules with an overall diameter of 200 to 220 A and a 90 A wide 
lucent center. Most frequently the lipid bodies were present within the 
cytoplasm of histiocytes and macrophages, many, however, were adjacent 
to nuclei of glial cells and rarely of astrocytes (Agamanolis et al, 
1976, 1979, Liu et al 1976). Lipids were not seen within the neurons. 
Agamanolis and Patre, 1979, described degenerative changes of the ecto­
pic Purkinje cells. Loose concentric membranous cytoplasmic bodies en­
closing a small amount of dense material, and concentric and parallel 
arrays of dense lines formed the two types of cytoplasmic inclusions. 
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Liver (80 patients) 
Macroscopic studies. 
In general, macroscopic examination of the liver of patients with CHR-S 
revealed hepatomegaly with normal gall bladder and extrahepatic bile 
ducts. 
Microscopic studies. 
Abnormalities in liver tissue were mentioned in all patients investiga-
ted. Microscopic studies of the liver in Zellweger syndrome showed in 
general slight or moderate alterations. Hepatic lobular disarray, con-
sisting of irregular spatial relationship between central and peripheral 
portions of the lobules, was a common finding (Gilchrist et al, 1976). 
Frequently (32 patients) intralobular fibrosis was observed. A few au-
thors mentioned cirrhosis (8 patients). Cholestasis was reported in 13 
patients, some of them showed epithelial proliferation of the bile ducts 
(Monnens et al, 1980). Progression of the intralobular fibrosis into 
cirrhosis was noted when successive biopsy and autopsy liver specimens 
were described (Gilchrist et al, 1976, Brun et al, 1978, Carlson and 
Weinberg, 1978, Pfeifer and Sandhage, 1979, and Mathis et al 1980). 
Prussian blue stain revealed moderate to heavy iron deposition in hepa-
tocytes and reticuloendothelial cells of liver in 36 children; in 4 
other cases no iron could be demonstrated. In eleven infants extramedul-
lary hematopoiesis was found. 
Giant cell transformation of liver cells was unusual (3 patients); it 
decreased during follow up (Carlson and Weinberg, 1978). 
The presence of PAS-diastase-positive macrophages was reported in three 
patients of different age (Mooi et al, 1983). 
Electron microscopic studies. 
The first electron microscopic studies on liver tissue of patients with 
Zellweger syndrome were reported by Goldfischer et al, 1972, 1973A, and 
1973B. Increased electron density of the matrix and distortion of the 
cristae of the mitochondria were generally noted (Goldfischer et al, 
1972, Brun et al, 1978, Hanson et al, 1979, Pfeifer and Sandhage, 1979, 
Monnens et al, 1980, Mathis et al, 1980, Hong et al, 1981, Borchard et 
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al, 1982, Mooi et al, 1983). Borchard et al (1982) and Mooi et al (1983) 
described giant mitochondria, frequently with paracrystalline inclu-
sions. Comparison of successive specimens revealed no progression of the 
mitochondrial abnormalities (Mooi et al, 1983). 
Peroxisomal abnormalities in CHR-S, demonstrated by enzyme-histochemical 
electron microscopy, were first mentioned in liver tissue by Goldfischer 
et al, 1973A and 1973B. After incubation in the alkaline DAB (diamino-
benzidine) medium for demonstrating the peroxidatic activity of catala-
se, a marker enzyme for peroxisomes no reactive peroxisomes could be 
found. His conclusion was: "if any peroxisomes are present in cerebrohe-
pato-renal syndrome our observations indicate that they must be greatly 
reduced in number or altered in form and enzymatic activity". An asser-
tion that a structure is absent, is difficult, if not impossible, to ma-
ke solely on the basis of morphologic studies. A lot of pathologic stu-
dies failed to visualize peroxisomes: Brun et al, 1978, Carlson and 
Weinberg, 1978, Pfeifer and Sandhage, 1979, Hanson et al, 1979, Friedman 
et al, 1980, Monnens et al, 1980, Hong et al, 1981, Müller-Höcker et al, 
1981, Borchard et al, 1982 and Björkhem et al, 1984. Müller-Höcker et al 
(1981) reported absence of peroxisomes in the liver, irrespective of du-
ration and degree of liver damage. Pfeifer and Sandhage (1979) proposed 
the term "peroxisomes deficiency" as a name for this syndrome which is 
more closely related to the pathogenetic mechanism than the usual desig-
nation cerebro-hepato-renal syndrome. 
Some authors reported a subtotal loss of peroxisomes (Carlson and Wein-
berg, 1978, Mathis et al, 1980, Borchard et al, 1982). Structures, pos-
sibly resembling microperoxisomes, were occasionally noted (Pfeifer and 
Sandhage, 1979, Borchard et al, 1982, Mooi et al, 1983), although no ca-
talase positivity of those structures was found. 
Lysosomal abnormalities in two older patients (12 months and 2 years and 
4 months of age, respectively), suffering from the CHR-S were mentioned 
in two reports. In liver macrophages, lysosomes, filled with fine double 
lamellae were noted, corresponding to the PAS-diastase positive material 
observed light microscopically (Pfeifer and Sandhage, 1979, Mooi et al, 
1983). The lamellae appeared as pairs of very fine electron-dense lines, 
slightly less than 10 nra, usually arranged parallel to one another 
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and to the main axis of the lysosome, and determining the angular or fu-
siform shape of the lysosomes (Mooi et al, 1983). Small numbers of simi-
lar lysosomes in hepatocytes were reported by Mooi et al (1983). 
Kidneys (71 patients) 
Macroscopic studies. 
Macroscopic studies of the kidneys in Zellweger syndrome showed in seve-
ral cases cortical cysts with a diameter up to 15 mm. 
Microscopic studies. 
Microscopic studies on kidney tissue from patients with the CHR-S revea-
led cysts throughout the kidney cortex in nearly every patient; occasio-
nally cysts in the medulla were reported (Patton et al, 1972, Vincens et 
al, 1973, Bernstein et al, 1974). There was no relationship between the 
number or size of cysts and the age at death. Exceptionally no abnorma-
lities of the kidneys were mentioned (Bowen et al, 1964, Gustafsson et 
al, 1983). No signs of scarring, cartilage or inflammation were found. 
Electron microscopic studies. 
Goldfischer et al, 1973A and 1973B, published the first report of elec-
tron microscopic studies on kidney tissue from patients with the CHR-S. 
They reported minimal mitochondrial changes in proximal tubulus cells. 
No structures resembling peroxisomes could be found by enzyme-histoche-
mical electron microscopy (Goldfischer et al, 1973B, Brun et al, 1978). 
Skeletal muscle - peripheral nerve 
In several muscles no abnormalities were reported (Passarge et al, 1967, 
Kohn and Mündel, 1969, Volpe and Adams, 1972, Garzuly et al, 1974, Gil-
christ et al, 1976) until Carlson and Weinberg (1978) and Müller-Höcker 
et al (1984) mentioned focal atrophy of skeletal muscle fibers and of 
fibers of the diaphragm (Müller-Höcker et al, 1984). Sarnat et al (1983) 
described a "mitochondrial myopathy". Their ultrastructural studies 
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showed large aggregates of mitochondria and increased lipid content in 
the subsarcolemmal and intermyofibrillar spaces. Müller-Höcker et al, 
1984, reported enlarged mitochondria with irregularly oriented cristae 
in the striated muscle while in the myocardium the number, size and sha-
pe of the mitochondria appeared normal. 
Light microscopic studies of the peripheral nerve in the CHR-S revealed 
"demyelination" (Kohn and Mündel, 1969, Liu et al, 1976), although other 
authors reported no abnormalities (Volpe and Adams, 1972, Gilchrist et 
al, 1976). Segmental fusiform enlargement of the axons was demonstrated 
(Liu et al, 1976). Brun et al, 1978, described axones of the peripheral 
nerves with irregular swellings of a "torpedo type", though without ob-
vious concomitant cellular reactions such as inflammatory cells or fi-
brosis. 
Electron microscopic study of the peripheral nerve showed many myelina-
ted nerve fibers, filled with an excess of neurofilaments which assume 
о 
a winding pattern. The individual filament measured approximately 80 A 
and morphologically they did not differ from those seen in normal ner­
ves. 
Hemato-lymphatic system (20 patients) 
The weight of the thymic gland was diminished in 4 out of 7 patients 
(Gilchrist et al, 1976). Diminished numbers of Hassall's corpuscles were 
mentioned by Opitz et al, 1969, Gilchrist et al, 1974, and Brun et al, 
1978. 
Siderosis of the spleen was mentioned by a few authors (Smith et al, 
1965, Kohn and Mündel, 1969, Jan et al, 1970, Goldfischer et al, 1973A, 
Haddad et al, 1976, Brun et al, 1978, Bartolettl et al, 1978), although 
no siderosis could be demonstrated in two patients (Liu et al, 1976, 
Carlson and Weinberg, 1978). 
Ultramicroscopic studies on spleen, thymus or lymphnode tissue were not 
reported. 
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Adrenal glands (10 patients) 
Only a few reports of histopathologic study on adrenal gland tissue of 
patients with CHR-S are available. 
In two patients the microscopic picture of the adrenal gland was consi-
dered to be normal (Punnett and Kirkpatrick, 1968, Brun et al, 1978). 
Goldfischer et al, 1983, reported a morphological study of adrenocorti-
cal tissue of 8 infants who had died of Zellweger syndrome. Histopatho-
logical study of the adrenocortical tissue revealed a normal architec-
ture and no evidence of atrophy. Striated cells, some of which were bal-
looned, were present in the reticularis-inner fasciculata of 7 from 8 
adrenals. Autolysis made interpretation of the eighth case uncertain. 
There were two types of striated cells. The commonest type of striated 
cell appeared to be adrenocortical parenchymal cells which occurred 
within normal trabeculae and were separated by sinusoidal spaces. The 
second type of striated cell was more eosinophilic with contracted cyto-
plasm and often an excentric small nucleus. 
Ultrastructural examination of these striated adrenocortical cells con-
firmed the presence of lamellae with 2.5 nm leaflets and lamellar-lipid 
profiles of very long chain fatty acid-cholesterol esters, lying free in 
the parenchymal cells and considered to be characteristic of ALD. A lot 
of non-parenchymal cells contained membrane-bound spicular inclusions. 
Pancreas (9 patients) 
Hyperplasia of the islands of Langerhans was reported by a few authors 
(Patton et al, 1972, de León et al, 1977, Brun et al, 1978 and Sarnat et 
al, 1983). Occasionally acinar tissue cysts were mentioned (Jan et al, 
1970, de León et al, 1977),. 
No ultramicroscopic studies on pancreas tissue were reported. 
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The eyes 
Macroscopic studies. 
Haddad et al, 1976, described an oedematous cornea. The angle of the 
iris was of normal appearance (Volpe and Adams, 1972, Haddad et al, 
1976), the etiology of the glaucoma could not be established in these 
patients. 
The lens exhibited early cataractous changes posteriorly (Haddad et al, 
1976). Normal optic discs (Volpe and Adams, 1972, Brun et al, 1978), op-
tic disc pallor (Punnett and Kirkpatrick, 1968, Stanescu et al, 1972, 
Vincens et al, 1973, de Leon et al, 1977, Agamanolis et al, 1976, Fried-
man et al, 1980) and macula degeneration (Garner et al, 1982) were re-
ported. Focal retinal hemorrhages and mottling of the retinal pigment 
epithelium in the mid and far periphery were noted (Volpe and Adams, 
1972, Cohen et al, 1983). 
Microscopic studies. 
Investigation of the sclera (Haddad et al, 1976, Toussaint et al, 1981, 
Garner et al, 1982), the filtration angle (Volpe and Adams, 1972, Haddad 
et al, 1976, Garner et al, 1982) and the iris (Toussaint et al, 1981, 
Garner et al, 1982, Cohen et al, 1983) revealed no abnormalities. An oe-
dematous cornea (Toussaint et al, 1981, Garner et al, 1982) with irido-
scleral adhesions (Haddad et al, 1976) was reported although other pa-
tients showed normal corneal appearance (Toussaint et al, 1981, Garner 
et al, 1982). 
The corpus ciliare was considered to be normal (Toussaint et al, 1981, 
Garner et al, 1982, Cohen et al, 1983); Haddad et al (1976) however re-
ported focal necrosis and scattered melanophages within the ciliary bo-
dy. 
The lens morphology varied between normal (Garner et al, 1982) and cata-
ractous abnormalities: subcapsular cortical degeneration (Haddad et al, 
1976), mottled lens fibers (Hittner et al, 1981, Kretzer et al, 1981) 
and subcapsular vacuoles (Kretzer et al, 1981, Cohen et al, 1983) were 
described. 
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The vitreous was condensed into strands, with many attached spindle-sha-
ped and mononuclear cells in 2 out of 3 patients (Cohen et al, 1983). 
Haddad et al, 1976, reported an unremarkable choroid and sclera; Cohen 
et al, 1983, described an area of extramedullary hematopoiesis within 
the choroid. 
Generally, the retinal abnormalities were mainly localized centrally 
while the periphery revealed pigment epithelium pathology. The following 
abnormalities were described: subepithelial, lipid-loaden macrophages 
(Toussaint et al, 1981, Kretzer et al, 1981), photoreceptor cell degene-
ration, mainly affecting the rods (Haddad et al, 1976, Kretzer et al, 
1981, Toussaint et al, 1981, Garner et al, 1982, Cohen et al, 1983), de-
creased number of the outer nuclear layer cells with normal inner nuclear 
layer and outer and inner plexiform layer (Haddad et al, 1976, Kretzer 
et al, 1981), Muller cell proliferation (Kretzer et al, 1981), diastase-
sensitive, PAS-positive crystalline material in the peripheral inner re-
tinal layers (Cohen et al, 1983). There was a marked decrease of ganglion 
cells (Haddad et al, 1976, Kretzer et al, 1981, Toussaint et al, 1981, 
Cohen et al, 1983), gliosis of the nerve fiber layer (Haddad et al, 1976, 
Cohen et al, 1981) with moderate loss of axons (Haddad et al, 1976, 
Toussaint et al, 1981), while the inner limiting membrane seemed to be 
thickened (Kretzer et al, 1981). 
The optic nerve was moderately atrophic (Opitz et al, 1969, Haddad et 
al, 1976, Agamanolis et al, 1976 and 1979, de Leon et al, 1977, Tous-
saint et al, 1981, Hittner et al, 1981, Kretzer et al, 1981, Garner et 
al, 1982, Cohen et al, 1983) with an increased number of large fibrilla-
ry astrocytic cells (Opitz et al, 1969, Haddad et al, 1976) and loss of 
axons (Haddad et al, 1976, Kretzer et al, 1981, Toussaint et al, 1981). 
Gliosis was mentioned several times (Haddad et al, 1976, Toussaint et 
al, 1981, Garner et al, 1982) as well as demyelination of the optic ner-
ve (Opitz et al, 1969, Haddad et al, 1976, Toussaint et al, 1981, Garner 
et al, 1982). 
Iron was demonstrated in the stratified squamous epithelium of the cor-
nea and the unpigmented epithelium of the ciliary body (Volpe et al, 
1972), and also in the choroid (Garner et al, 1982, Cohen et al, 1983). 
Haddad et al, 1976 and Toussaint et al, 1981 found no iron in the ocular 
structures. 
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Electron microscopie studies. 
Transmission electron microscopie studies on the ocular tissues were re-
ported since 1976. Except for interstitial corneal oedema (Haddad et al, 
1976), the cornea, sclera and iris did not reveal ultrastructural abnor-
malities (Toussaint et al, 1981). The lenticular opacities had ultra-
structural analogues, which were inclusion bodies restricted to the cor-
tical lens fibers and interspersed between osmiophilic dense core granu-
les. Despite the presence of abnormal mitochondria in the lens epithe-
lium, the inclusions were not neutral lipid. The lens epithelium showed 
abnormal mitochondrial proliferation with pale matrix and few cristae, 
increasing from 18% of the cytoplasmic area at 2.5 months to 23% at 10.5 
months. In age-matched controls this was only 5% (Hittner et al, 1981). 
The retinal pigment epithelium was flattened and contained a variable 
amount of melanin (Toussaint et al, 1981, Garner et al, 1982). Presumed 
premelanosomes sometimes were lying in the subretinal space (Garner et 
al, 1982). Toussaint et al (1981) and Cohen et al (1983) reported bi-
leaflet inclusions in the retinal pigment epithelium and in pigmented 
macrophages. The electron-dense leaflets were 2.2 nm in diameter and 
were separated by a 2.2 nm electron-lucent space, the leaflet having no 
membrane and being intermixed with a fine granular background substance 
(Cohen et al, 1983). If the leaflets were not admixed in loose conglome-
rates but in densely packed whorls their thickness was 3.7 nm and they 
were separated by a 3.1 nm electron-lucent space. 
Many of the photoreceptor cells were degenerative. They were represented 
by sparse debris, some forming laminated myelin figures (Garner et al, 
1982), others had shed almost all the outer discs (Toussaint et al, 
1981, Garner et al, 1982). The inner segment showed considerable loss of 
mitochondria. Residual mitochondria often were swollen with ring and 
other abnormal cristae (Garner et al, 1982). The macrophages in the sub-
retinal space contained large round inclusion bodies similar to those of 
the retinal pigment epithelium (Toussaint et al, 1981, Cohen et al, 
1981). 
No reports concerning lysosomes and peroxisomes in ocular tissues of 
Zellweger patients are available. 
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Biochemical analysis of the cholesterol ester fraction of the retinal 
tissues revealed a more than fivefold Increase in very long chain fatty 
acids compared with age-matched controls (Cohen et al, 1983). 
In a biopsy of the conjunctiva. Inclusion bodies, resembling neutral li-
pids, were noted in the cytoplasm of the vascular endothelial cells and 
in the Schwann cells (Toussaint et al, 1981). 
Other organs 
Histopathologic studies of the cardiovascular system in Zellweger syn-
drome revealed congenital abnormalities in 14 patients, usually patent 
ductus arteriosus and/or septum defect(s). 
Abnormalities in lung tissue were reported in 24 patients with the CHR-S 
Pneumonia was mentioned in 20 patients, eight times atelectasis was 
found. 
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BIOCHEMICAL STUDIES 
Introduction 
A survey of the biochemical abnormalities mentioned in the literature 
about cerebro-hepato-renal syndrome is given in Table VII. The unusual 
variety of metabolic disturbances is remarkable. 
TABLE IV: Biochemical abnormalities described in the cerebro-hepato-
renal syndrome of Zellweger. 
Biochemical abnormalities 
Liver dysfunction 
Iron overload 
Mitochondrial dysfunction 
Peroxisomal dysfunction or absence 
Immune deficiency 
ΗΡΑ, HPa 
Defect in PA catabolism 
Defect in bile acid synthesis 
Increased p-OH-phenyllactate in urine 
Dicarboxylic aciduria 
Increased level of VLCFA in fibro­
blasts (saturated and С , ) 
Mitochondrial defect 
Deficiency of plasmalogens in tissues 
Increased level of saturated VLCFA 
in serum 
Deficiency of acyl-CoA:DHAP acyltrans-
ferase 
Author 
Bowen 
Vitale 
Goldfischer 
Goldfischer 
Gilchrist 
Danks 
Trijbels 
Hanson 
Chalmers 
Chalmers 
Brown, Moser 
Trijbels 
Heymans 
Bakkeren 
Schutgens 
Year 
1964 
1969 
1972 
1973 
1974 
1975 
1979 
1979 
1980 
1980 
1982, 
1981, 
1983 
1984 
1984 
1983 
1983 
VLCFA = very long chain fatty acids (C,,-C ) 
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Iron overload 
The first "specific" metabolic derangement described was excessive iron 
content of several tissues. Deposition of iron in the (reticulum cells 
of the) spleen (Smith et al, 1968, Kohn and Mündel, 1969) and in the 
reticulum cells of the liver (Kohn and Mündel, 1969) was described, 
without determination of the serum iron concentration. 
Opitz et al (1969) performed studies of the iron metabolism in one pa-
tient. An unusually high serum iron level was measured. The bone marrow 
macrophages contained large amounts of stored iron and hepatic hemoside-
rosis was documented before death. After death at the age of six months, 
the iron concentration in various tissues was determined. A significant 
increase of iron was found in the liver and the kidneys. The total body 
iron concentration was estimated to be 114 mg/kg body weight which re-
presented a 52% increase over the normal value of 75 mg/kg. An excess of 
plasma iron was proposed to establish the diagnosis of Zellweger syndro-
me in a suspected infant. The iron in CHR-S is mostly localized in the 
reticuloendothelial system rather than in parenchymal cells and corre-
lates poorly with liver disease (Gilchrist et al,1976, Kelley, 1983, 
Müller-Höcker et al, 1984). 
Normal and increased levels of serum iron and/or iron binding capacity 
were reported. Gilchrist et al (1976) demonstrated that the iron content 
of the liver was generally increased, rose to a plateau between 5 and 18 
weeks at a level 3-5 times that found in control tissue, and dropped to 
normal levels in infants living longer than 20 weeks. The pathogenesis 
of this "early" disturbance in the iron metabolism is unclear. 
Pipecolic acid (PA) metabolism 
Introduction 
Mild aspecific amino aciduria in Zellweger syndrome was mentioned by se-
veral authors (Jan et al, 1970, Poznanski et al, 1970, Volpe and Adams, 
1972, Vincens et al, 1973, Sommer et al, 1974, Garzuly et al, 1974) un-
til Danks et al (1975) reported hyperpipecolic aciduria (HPa) in 4 and 
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hyperpipecolic acidemia (ΗΡΑ) in 2 patients. A disturbance in the meta­
bolism of pipecolic acid (PA) in CHR-S was shown by Trijbels et al 
(1979). The range of PA levels in urine, serum and CSF observed in CHR-S 
is given in Chapter III. 
The metabolism of pipecolic acid (PA) 
Rothstein et al (1953, 1954, 1959) found evidence that L-lysine is con­
verted to PA in rat liver. Chang et al (1976, 1978A) demonstrated by 
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means of intraventricular injection of С -labeled L- and D-lysine 
that both isomers (D more effectively than L) were metabolized in rat 
brain in a considerable amount to labeled L-PA and to a minor amount 
further into o-amino-adipic acid. The presumed metabolic routes of L-
lysine via saccharoplne and via PA are shown in Figure 2. While lysine 
is mainly metabolized via saccharoplne in most organs, especially the 
liver, evidence has been obtained that in rat brain, the conversion of 
lysine to PA is the major metabolic pathway (Chang, 1976, Giacobini et 
al, 1980). PA can be converted in vivo and in vitro into piperidine in 
the rat brain (Kasé et al, 1967, 1970). 
The piperidine levels in Zellweger syndrome are unknown. 
In 2 Zellweger patients oral loading tests with L-lysine revealed lysine 
levels comparable to the control values without significant increase of 
the PA level in serum, urine and CSF (Trijbels et al, 1979). Therefore, 
the elevated levels of PA in CHR-S are not due to a disturbance in the 
metabolism of L-lysine via the saccharoplne route resulting in an 
overflow to the PA pathway. 
Oral loading tests with (150 mg/kg body weight) DL-PA hydrochloride in 
controls and in 3 Zellweger patients revealed in the patients a delayed 
return of the serum PA level to the baseline value as compared to con-
trol subjects proving that the HPa in CHR-S could be explained by a 
defect in the catabolism of PA (Trijbels et al, 1979). Dancis and Hutz-
ier (1982) studied the metabolism of PA in liver and kidney tissue from 
10 different animal species. Remarkable differences, in the metabolic 
rate, to 1000 fold, were noted among the species. The highest activity 
was found in rabbit and guinea pig kidney. In the adult human kidney PA 
was also metabolized. 
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Fig. 2: Metabolie routes of L-lysine via saccharopine and via pipecolic 
acid (according to Trijbels et al, 1979). 
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Blood-brain barrier and distribution of lysine, PA and piperidine 
The blood-brain barrier transport of L-lysine in the rat was studied by 
Chang (1978B) through the use of intravenous pulse injection of L С 
lysine. Chang (1978B) concluded that the L-lysine blood-brain barrier 
transport system of the rat was not saturated, even at the high dose (30 
mg/kg) of L С lysine used. The low level of PA in human urine, compa­
red with the rat, would indicate a much stronger lysine blood-brain 
transport barrier in man than in the rat. 
Labeled PA administered intracarotidly, intravenously or intraperito-
neally, was actively transported in vivo into the mouse and rat brain 
(Nishio et al, 1981A, 1981B and 1983, Charles et al, 1983). In adult 
rats the cerebral cortex showed the highest uptake (Charles et al, 
1983), while in newborn mice brain the preferential localization of the 
accumulated radioactivity was the olfactory bulb, the anterior telence­
phalon and the diencephalon (Nishio et al, 1983). 
Kinetic studies of L-PA influx revealed a saturable low- and a non-satu-
rable high-capacity uptake mechanism in rats (Charles et al, 1983). An 
age-dependent difference in blood-brain barrier for PA in mice was sug­
gested by the age-dependent pattern of accumulation of radioactivity in 
the CNS after intraperitoneal administration of I С PA (Nishio et al, 
1983). In newborn mice the accumulation of radioactivity in CNS reached 
a peak 24 h after intraperitoneal injection of D, L H PA whereas in 
adult mice radioactivity in CNS peaked at 5 min, remained approximately 
constant up to 5 h and then declined slowly to 24 h. The radioactivity 
in plasma showed essentially the same pattern of accumulation in adult 
and in newborn mice. 
Structurally related substances, such as nipecotic acid, isonipecotic 
acid, L-proline, piperidine and GABA showed an inhibitory effect on the 
active blood-brain transport of PA in mice (Nishio et al, 1981В). 
The regional distribution of labeled piperidine in rabbit brain after 
intravenous injection of the labeled substance revealed the highest le­
vels in the nucleus caudatus, the anterior neocortex and the corpora 
quadrigemina (Abood et al, 1961). 
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The pipecolic acid metabolism and the peroxisomes 
The exact mechanism of PA metabolism in man, including the subcellular 
localization of this metabolic route is not known. The association of a 
disturbance in the metabolism of PA with the deficiency of peroxisomes 
in the Zellweger syndrome however points to a specific function of 
peroxisomes in this degradative pathway. Preliminary experiments per­
formed by our group, have proven that isolated rat liver peroxisomes 
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show FAD dependent metabolic activity against 1- CI PA. 
Liver dysfunction - Abnormal bile acid pattern 
Jaundice persisting after the seventh day of life and/or hepatomegaly 
and/or gastro-intestinal bleeding called attention to the liver. Eleva­
ted transaminases, yGT, LDH and direct bilirubin were conspicuous fin­
dings. Usually hypoprothrombinemia, corrected by Vit К administration, 
was mentioned. Normal "liver function tests" were occasionally noticed 
(Taylor et al, 1969, Sommer et al, 1974, Garzuly et al, 1974, Mathis et 
al, 1980). 
The presence of abnormal bile acids in CHR-S was first mentioned by Han­
son et al (1979), and confirmed by Monnens et al (1980) and Mathis et al 
(1980). An abnormal accumulation of the bile acid precursors trihydroxy-
coprostanic acid (THCA) and dihydroxycoprostanic acid (DHCA) and some­
times varanic acid (an intermediate between THCA and cholic acid) in 
duodenal fluid, serum and urine was documented (see Fig. 6, Chapter I). 
These compounds are considered to be normal intermediates in the degra­
dation of the cholesterol side chain in the biosynthesis of cholic acid 
and chenodeoxycholic acid (Hanson et al, 1979, Danielsson and Gustafs-
son, 1981). The presence of moderate amounts of cholic and chenodeoxy­
cholic acid in the patients indicates that the block in the side chain 
oxidation is a partial one (Mathis et al, 1980). Hanson et al (1979) 
and Gustafsson et al (1983) reported varying levels of these precursors 
during follow up of patients with CHR-S. Absence of DHCA at very young 
age (2 patients) and a decreasing level of THCA with increasing concen­
tration of varanic acid (2 patients) were noted. A causal relationship 
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between the abnormal levels of bile acids and the liver disease was sug-
gested by Hanson et al (1977), Monnens et al (1980) and Borchard et al 
(1982). Pedersen and Gustafsson (1980) and Kase et al (1983) showed that 
the peroxisomal fraction of rat liver homogenate is able to catalyse the 
conversion of THCA into cholic acid. The presence of THCA and DHCA in 
duodenal fluid, serum and urine is important for the biochemical diagno-
sis of CHR-S (Monnens et al, 1980, Mathis et al, 1980, Gustafsson et al, 
1983). These bile acids were not found in controls with other causes of 
cholestasis (Boon et al, 1973, Lott et al, 1979). 
In serum of one patient with all symptoms of the Zellweger syndrome, 
Parmentier et al (1979) reported the presence of 3a, 7a, 12a- trihydro-
xy-50-C29 dicarboxylic bile acid. Small amounts were detected in bile 
and urine. The same abnormal bile acid was reported in plasma of one 
Zellweger patient by Björkhem et al, 1984, although specific search for 
that bile acid by Gustafsson et al (1983) was unsuccessful in serum of 
one patient. 
Collins et al (1978) identified 26-hydroxycholesterol in serum of one 
Zellweger patient. Analysis of serum from 22 other infants with a va-
riety of liver diseases failed to identify 26-hydroxycholesterol. 
Immune deficiency 
The pathologic findings of the hemato-lymphatic system have been descri-
bed previously. Immune deficiency in the CHR-S was suggested by these 
findings (Gilchrist et al, 1974). The usual assays of cellular immunity 
(number of lymphocytes, stimulation of the lymphocytes from the periphe-
ral blood by phytohemagglutinin and pokeweed mitogen, mixed lymphocyte 
reaction, resetting tests) were found to be normal in 1 patient by Bak-
keren et al (1976). Camera et al (1977) and Brun et al (1978) reported 
normal Τ en В cell function. Hong et al (1981) however reported a combi­
ned Τ en В deficiency in one patient. This patient had a decreased level 
of serum calcium in association with immunodeficiency. Hypocalcemia was 
never observed in our patients with CHR-S. No systematic analysis of 
cellular and humoral immunity in patients with CHR-S has been reported. 
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Organic aciduria 
Chalmers et al (1980) listed two siblings with CHR-S manifesting an ab­
normal dicarboxylic aciduria. No further details were given. Kelley 
(1983) mentioned also dicarboxylic aciduria in two older patients with 
CHR-S. This can possibly be related to the carnitine deficiency in their 
patients (Kelley, 1983). In twelve of our patients no dicarboxylic aci­
duria could be found by gas chromatography. 
Increased excretion of p-OH-phenyllactate in urine was first reported by 
Brun et al, 1978. Chalmers et al (1980) and Govaerts et al (1982) con­
firmed this observation (in 2 and 7 patients respectively). Seven new 
patients investigated by our group showed increased excretion of p-OH-
phenyllactate in urine (>120 pmol/mmol creatinine). No specific metabo­
lic defect could be deduced as yet from this observation. 
Very long chain fatty acids (VLCFA) pattern 
Brown et al (1982) found increased levels of C-.-C», saturated fatty 
acids in brain white matter, adrenal gland and cultured fibroblasts from 
Zellweger patients. The increase was similar to that noted in adrenoleu-
kodystrophy (ALD). Increased concentration of hexacosanoic acid (C^^.) 
was consistently found in the serum of patients with CHR-S (Bakkeren et 
al, 1984). The ratios С2б С22-0' C25-0 / C22-0' a n d C24-0/C22-0 i n s e r u m 
were also elevated compared to age-matched controls. The concentrations 
and ratios in serum of heterozygotes were within normal ranges. Further 
investigation of the saturated VLCFA levels and ratios in cultured fi­
broblasts of patients, heterozygotes and controls and in amnlocytes from 
pregnancies not at risk for CHR-S (Moser et al, 1984, Chapter V) reveal­
ed comparable results. The VLCFA are preferentially degraded by peroxi­
somal 0-oxidation (Kawamura et al, 1981). Impaired degradation of the 
VLCFA in cultured skin fibroblasts from Zellweger patients was reported 
(Moser et al, 1983, Moser et al, 1984). Antenatal diagnosis for this 
disease by means of determination of the saturated VLCFA in amnlocytes 
was suggested (Brown et al, 1982, Bakkeren et al, 1984), and performed 
by Moser et al (1984). 
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Not only the levels of saturated VLCFA but also of hexacosenoic acid 
(C., .) were increased in plasma and in cultured skin fibroblasts of 
patients suffering from CHR-S (Moser et al, 1983, Moser et al, 1984, 
Björkhem et al, 1984). In amniotic fluid from a pregnancy affected by 
CHR-S similar abnormalities of the VLCFA were reported (Björkhem et al, 
1984). 
The increased VLCFA levels in erythrocyte membranes (Tsuji et al, 1981, 
Kobayashi et al, 1983, Knazek et al, 1983) and in cholesterol esters of 
the brain white matter (Brown et al, 1983), mentioned in ALD, have not 
(yet) been reported in CHR-S. 
Deficiency of plasmalogens in tissues 
A severe deficiency of plasmalogens in several tissues of Zellweger pa-
tients was reported by Heymans et al (1983, 1984). Phosphatidylethanola-
mine plasmalogen and phosphatidylcholine plasmalogen were nearly absent 
in tissues of patients with CHR-S. The phosphatidylethanolamine plasma-
logen concentration in cultured skin fibroblasts was significantly de-
creased compared to controls and heterozygotes. A general defect in al-
kyl ether phospholipid synthesis was proposed. Lowered, but substantial 
amounts of plasmalogens in erythrocytes of patients were an intriguing 
finding. 
Schutgens et al (1984) reported a severe deficiency of acylCoA:DHAP 
acyltransferase, the first enzyme in the pathway leading to plasmalogen 
biosynthesis in liver, brain and cultured skin fibroblasts from Zellwe-
ger patients. Acyl-CoA:DHAP acyltransferase is probably localized on the 
inside face of the peroxisomal membrane (Hajra and Bishop, 1979 and 
1982). Cultured amniotic fluid cells from pregnancies not at risk for 
CHR-S contained an enzymatic activity comparable to that of control fi-
broblasts. A prenatal test for this disease based on the deficiency of 
acyl-CoA:DHAP acyltransferase in cultured amniotic fluid cells is now 
available. 
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Mitochondrial defects in the CHR-S; 
relation to the deficiency of peroxisomes 
Mitochondrial defects and absence of peroxisomes in the cerebro-hepato-
renal syndrome were first described by Goldfischer et al (1972, 1973A 
and 1973В). These authors demonstrated cytochemically, with a diamino-
benzidine staining technique, the absence of peroxisomes in hepatocytes 
and renal proximal tubules. Oxygen consumption by brain mitochondria of 
a Zellweger patient was severely reduced with several substrates (succi­
nate, glutamate and malate). Respiration rate was not stimulated by ad­
dition of ADP. Normal oxygen consumption was found with ascorbate and 
TMPD (tetramethylphenylenediamine), transferring electrons directly to 
the cytochromes. Liver mitochondria from a second patient showed similar 
results. From these observations Goldfischer et al (1973B) concluded 
that there must be a defect in the electron transport chain before the 
step involving cytochromes. From histochemical studies in brain, liver 
and muscle from a Zellweger patient, they postulated that the defect is 
most probably located between the succinate dehydrogenase flavoprotein 
and coenzyme Q. A schematic representation of the respiratory chain is 
given in Fig. 3. Mitochondria in liver were reduced in number and their 
cristae were irregular. 
Mitochondrial and peroxisomal defects were reported by Versmold et al 
(1977) in a patient with a disorder similar to Zellweger syndrome. Liver 
of this patient showed no peroxidatic activity of catalase and peroxiso­
mes were absent. Most mitochondria isolated from patient's liver showed 
normal appearance. In contrast to the findings of Goldfischer et al 
(1973) these authors found almost normal succinate and glutamate respi­
ration in liver mitochondria of their patient. Coupling of respiration 
to phosphorylation was also normal. Isolated liver mitochondria showed a 
strongly reduced cytochrome content (one third of normal). Brain mito­
chondria showed a normal cytochrome content. Versmold et al (1977) did 
not provide an explanation for the relationship between the defects in 
mitochondria and peroxisomes. 
Considering the studies performed by Goldfischer et al (1973) and Ver­
smold et al (1977) it can be concluded that mitochondrial defects have 
been reported by both of them. However, the localization of the defect 
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Fig. 3: Schematic representation of the respiratory chain composed of 
coenzyme Q (=Q) and cytochromes a, b and c, and its interaction 
with two dehydrogenases supplying reduction equivalents. 
The succinate dehydrogenase coupled Q pool is not necessarily 
separated from the NADH dehydrogenase coupled Q pool. 
The interaction sites of various non-competitive inhibitors is 
shown by transverse lines. 
DCPIP is the artificial acceptor used in the succinate dehydro­
genase assay. TTFA inhibits the PMS mediated DCPIP reduction in 
a nearly competitive way. 
succinate 
succinate 
dehydrogenase 
•TTFA Ж 
Q 
NADH- NADH dehydrogenase 
PMS DCPIP 
| - * Q •b—J^c, ю • а а з — 1 - * 0 2 
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KCN 
DCPIP = dichlorophenol indophenol 
TTFA = 2-thenoyltrifluoroacetone 
PMS = phenazine methosulfate 
HQNO « 2-heptyl-4-hydroxyquinoline-N-oxide 
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in the electron transport chain was different: before the step involving 
the cytochromes according to Goldfischer et al (1973) and in the cyto 
chrome regio according to Versmold et al (1977). Goldfischer et al 
(1979) speculated that the peroxisomal and mitochondrial abnormalities 
in the CHR-S are different manifestations of a single defect. 
Biochemical studies in muscle, liver, leucocytes and fibroblasts from 
patients with the Zellweger syndrome have been performed by Trijbels et 
al (1983). Oxidation rates of several substrates (pyruvate, malate and 
2-oxoglutarate) were strongly reduced in skeletal muscle homogenate, the 
mean residual activity being 20% of controls. Liver homogenates from 
Zellweger patients incubated with succinate or glutamate and malate as 
substrates showed oxidation rates as low as 10% of controls. Oxygen 
consumption by isolated skeletal muscle mitochondria was not stimulated 
by addition of substrates (pyruvate and malate, succinate and rotenone), 
except for ascorbate and TMPD. This finding is in agreement with that of 
Goldfischer et al (1973) for brain mitochondria from a patient. 
Cytochrome content in mitochondria from heart muscle and liver was nor-
mal, in contrast to the strongly reduced values found by Versmold et al 
(1977) in liver mitochondria from their patient. This finding of a normal 
cytochrome content agrees with the proposed defect in the electron 
transport chain being localized prior to the cytochromes according to 
Goldfischer et al (1973). In order to localize the defect Trijbels et al 
(1983) investigated the succinate-ubiquinone oxidoreductase activity of 
a liver homogenate from a CHR-S patient using DCPIP (dichlorophenol in-
dophenol) as electron acceptor. The measured activity was very low. The 
defect was further elucidated by measuring the succinate-PMS (phenazine 
methosulphate) oxidoreductase activity as well as the characteristic 
TTFA (2-thenoyltrifluoroacetone) inhibition of this activity. The rate 
of reduction of PMS is not affected in the patient but the effect of 
TTFA is very close to the effect of a competitive inhibitor, in contrast 
to a non-competitive inhibition in control homogenate. These findings 
indicate (Trijbels et al, 1983) that the interaction of succinate dehy-
drogenase with ubiquinone is largely disturbed. Alternatively, a defi-
ciency of ubiquinone may account for the registered defect. The proposed 
disturbed interaction between succinate dehydrogenase and ubiquinone 
might be caused by or related to the deficiency of peroxisomes in the 
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cells of Zellweger patients. Deficiency of peroxisomes can lead to a 
disturbance in the structure of the inner mitochondrial membrane, as 
biosynthetic pathways of components of biologic membranes may be pre­
sent in peroxisomes. The defect in the electron transport chain can thus 
be caused by the disturbance in the structure of the mitochondrial mem­
brane. The localization of the defect in the electron transport chain at 
the level of succinate-ubiquinone oxidoreductase is in agreement with 
the proposal of Goldfischer et al (1973). 
Intact leucocytes and fibroblasts from Zellweger patients showed normal 
Γ 14 1 Γ 14 1 
oxidation rates of 1- CI pyruvate and 12- С pyruvate, suggesting a 
normally functioning electron transport chain in these cells. Indica­
tions for a similar condition in vivo were obtained by the finding of 
normal ratios of lactate/pyruvate and ß-hydroxybutyrate/acetoacetate in 
blood of Zellweger patients (Trijbels et al, 1983). However, the normal 
ratios do not necessarily exclude a defect in the electron transport 
chain in vivo because a drastic lowering of the oxidative capacity is 
required to cause a change in the NADH/NAD or lactate/pyruvate ratio. 
Kelley and Corkey (1983) investigated the effect of several inhibitors 
of mitochondrial electron transport in fibroblasts from Zellweger pa-
tients. Growth velocity of Zellweger cells and control cells was equally 
inhibited by amytal, rotenone, and 2-heptyl-4-hydroxyquinoline-N-oxide, 
whereas cells from Zellweger patients showed a five-fold greater sensi-
tivity to antimycin A, an inhibitor of the cytochrome be. complex, as 
compared to control cells. The authors suggested a primary or secondary 
functional deficiency at mitochondrial complex III in fibroblasts from 
Zellweger patients, in contrast with the defect at complex II proposed 
by Trijbels et al (1983). 
A mitochondrial myopathy in a case of Zellweger syndrome was reported by 
Müller-Höcker et al (1984). Enlarged mitochondria with minor structural 
abnormalities were found in skeletal muscle. Histochemically normal ac-
tivities of NADH-reductase, succinate dehydrogenase and cytochrome с 
oxidase were noted. The oxidative phosphorylation was found to be dis­
turbed. According to the authors a loosely coupled oxidative phosphory­
lation was present in patient's muscle. 
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Summarizing it can be concluded that several defects have been postu-
lated in the functioning of the electron transport chain in the Zell-
weger syndrome. It remains uncertain, however, whether these different 
defects all originate from the basic defect in this syndrome, being the 
deficiency of peroxisomes. It cannot be excluded that some observed mi-
tochondrial defects appear in vitro during manipulation of the patients' 
specimens owing to a structural defect in the mitochondrial membrane 
initiated by the peroxisomal deficiency. 
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RELATED DISORDERS 
Introduction 
A few syndromes described in literature show clinically and/or biochemi­
cally common features with the CHR-S. These syndromes and their classi­
fication number in McKusick's "Mendelian Inheritance in Man" are presen­
ted in Table V. 
Table V: Disorders related to CHR-S and their classification. 
Name of the disorder 
hyperpipecolic acidemia (ΗΡΑ) 
trihydroxycoprostanic acidemia 
neonatal adrenoleukodystrophy 
infantile phytanic acid storage 
disease 
Classification according 
to McKusick 
* 23940 
27565 
20237 
not classified 
These four diseases are inherited as an autosomal recessive trait. A 
review of the literature, concerning the sex of the patients, the age 
and cause of death is given in Tables VI, VII and VIII. The relation 
between CHR-S and neonatal ALD is discussed in Chapters V and VIII. 
A comparison of the clinical features and biochemical abnormalities of 
ΗΡΑ and neonatal ALD with those of the CHR-S is made in Tables IX and X. 
The infantile phytanic acid storage disease (Scotto et al, 1982, Yao et 
al, 1982) shares a lot of clinical and pathologic features with the 
CHR-S. Thin layer chromatography of serum of four of our CHR-S patients 
revealed an increased phytanic acid level compared to age-matched con­
trols (unpublished results). Further biochemical investigation of pa­
tients with infantile phytanic acid storage disease is required to deli­
neate whether or not this condition differs from the CHR-S. 
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TABLE VI: Hyperplpecolatemia. 
Case 
1 
2 
3 
4 
5 
6 
7 
Author 
Gatfield 
Thomas 
Roesel 
Roesel 
Burton 
Burton 
Arneson 
Year 
1968 
1975 
1979 
1979 
1981 
1981 
1982 
Sex 
M 
M 
7 
? 
M 
M 
F 
Age at 
> ih 
2 
? 
2 
1% 
3*5 
10*5 
death 
У 
У 
У 
У 
У 
m 
Cause of death 
not mentioned 
pneumonia 
not mentioned 
not mentioned 
respiratory insufficiency 
not mentioned 
intestinal hemorraghe 
TABLE VII: Trlhydroxycoprostanlc acidemia - Zellweger-like syndrome. 
Case 
1 
2 
3 
4 
5 
6 
7 
Author 
Eyssen 
Eyssen 
Boon 
Hanson 
Hanson 
Parmentier 
Parmentier 
Year 
1972 
1972 
1973 
1975 
1975 
1979 
1979 
Sex 
M 
F 
M 
M 
F 
M 
M 
Age at 
6 
8% 
4 
8 
23 
3*5 
born 
death 
m 
m 
m 
m 
m 
m 
in 1976 
Cause of death 
pneumonia 
not mentioned 
not mentioned * 
liver failure 
liver failure 
pneumonia 
alive 
* shock during dehydration (personal communication. Boon) 
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TABLE VIII: Patients with neonatal adrenoleukodystrophy. 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Author 
Ulrich 
Manz 
Man ζ 
Benke 
Benke 
Jaffe 
Jaffe 
Brown 
Brown 
Mobley 
Haas 
Partin 
Partin 
Farrell 
Noetzel 
Noetzel 
Year 
1978 
1980 
1980 
1981 
1981 
1982 
1982 
1982 
1982 
1982 
1982 
1983 
1983 
1983 
1983 
1983 
Sex 
M 
M 
M 
F 
M 
M 
F 
M 
F 
F 
F 
F 
M 
M 
M 
F 
Age of death 
18/12 
> 6h 
7 
28/12 
23/12 
15/12 
2 
> Ъ
1/2 
22/12 
27/12 
5 
22/12 
? 
> Us 
> lObi 
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У 
У 
У 
У 
y 
У 
У 
y 
y 
У 
У 
y 
У 
y 
y 
Cause of death 
not mentioned 
not mentioned 
pneumonia 
respiratory arrest 
respiratory arrest 
sudden death 
sudden death 
not mentioned 
not mentioned 
not mentioned 
pneumonia 
not mentioned 
not mentioned 
not mentioned 
not mentioned 
sudden death 
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TABLE IX: The clinical symptoms of the cerebro-hepato-renal syndrome 
(CHR-S) and two related diseases as reported in the litera­
ture. 
Clinical symptoms 
Craniofacial features 
high forehead 
frontal bossing 
large fontanels 
epicanthal folds 
hypertelorism 
abnormal ears 
high arched palate 
shallow supra-orbital ridge 
Central nervous system 
hypotonia 
seizures 
poor sucking 
poor activity 
absent reflexes 
hearing impairment 
reaction to painstimuli 
psychomotor retardation 
Eye symptoms 
nystagmus 
cloudy cornea 
cataract-lenticular opacities 
glaucoma 
clumping of pigment at the 
periphery 
optic disc pallor 
Other symptoms 
hepatomegaly <1/12 y 
>1/12 y 
jaundice after 7 days 
macroscopical gastro-intes­
tinal bleeding 
splenomegaly 
souffle in corde 
cryptorchidism 
cliteromegaly 
pes equinovarus 
ulnar deviation of the hand(s) 
simian crease(s) 
failure to thrive 
CHR-S 
32/32 
11/12 
38/39 
18/20 
19/22 
40/41 
23/24 
17/17 
75/79 
41/41 
45/46 
31/33 
45/47 
5/8 
8/8 
18/18 
20/20 
15/15 
17/18 
7/9 
6/7 
9/11 
27/36 
30/40 
19/20 
9/9 
11/16 
14/17 
16/17 
9/12 
34/38 
6/6 
19/21 
52/89 
ΗΡΑ 
2/2 
4/4 
1/1 
0/1 
1/2 
1/3 
5/5 
4/4 
3/3 
3/3 
1/1 
4/4 
3/4 
1/1 
4/4 
4/4 
2/3 
5/5 
1/1 
1/4 
0/2 
0/4 
0/1 
3/4 
4/5 
Neonatal 
ALD 
3/3 
1/1 
1/1 
1/1 
3/4 
2/2 
3/4 
12/14 
9/10 
5/5 
1/1 
5/7 
7/7 
1/1 
13/13 
2/2 
2/2 
1/1 
5/5 
4/4 
6/6 
1/2 
1/8 
0/2 
1/2 
5/6 
our 
CHR-S 
patients 
13/15 
6/12 
12/12 
10/12 
0/6 
7/13 
6/7 
10/10 
15/16 
12/16 
16/16 
16/16 
15/16 
5/5 
7/7 
16/16 
10/11 
2/6 
0/6 
0/3 
4/11 
8/11 
0/15 
15/16 
8/16 
1/16 
3/4 
5/16 
6/13 
1/2 
6/16 
5/16 
11/16 
14/16 
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TABLE X: The biochemical abnormalities of CHR-S and two related disorders 
as mentioned in literature. 
Biochemical abnormalities 
Amino-acids 
ΗΡΑ 
НРа 
increased PA in CSF 
abnormal DL-PA loading test 
Liver dysfunction 
increased serum transami­
nases, increased yGT 
increased direct bilirubin 
hypoprothrombinemia 
THCA in duodenal fluid 
serum 
urine 
DHCA in duodenal fluid 
serum 
urine 
Other 
albuminuria 
increased p-OH-phenyl-
lactate in urine 
CHR-S 
4/6 
16/17 
3/3 
20/25 
12/17 
11/14 
1/1 
4/5 
2/3 
14/19 
2/2 
ΗΡΑ 
6/6 
5/5 
1/1 
5/5 
3/5 
0/1 
2/3 
Neonatal 
ALD 
0/2 
0/2 
4/4 
our 
CHR-S 
patients 
10/10 
14/14 
8/8 
8/8 
14/14 
14/15 
8/9 
8/8 
9/9 
3/3 
7/8 
7/9 
1/3 
5/14 
9/9 
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Hyperpipecolic acidemia (ΗΡΑ) - hyperpipecolic aciduria (НРа) 
A number of authors mentioned similarities between the clinical and bio­
chemical features of the CHR-S and those of the hyperpipecolic acidemia 
(Trijbels et al, 1979, Burton et al, 1981, Arneson et al, 1982, Govaerts 
et al, 1982, Kelley, 1983). The resemblance of the clinical and bioche­
mical abnormalities of the latter disease to CHR-S is striking (see Ta­
bles IX and X). These patients presented with hypotonia, psychomotor re­
tardation and hepatomegaly; their facial dysmorphic features were gene­
rally noted (Thomas et al, 1975, Burton et al, 1981, Arneson et al, 
1982). 
The PA loading tests of patients with ΗΡΑ and of patients suffering from 
the CHR-S revealed similar patterns (Gatfield et al, 1968, Thomas et al, 
1975, Burton et al, 1981, Arneson et al, 1982, Trijbels et al, 1979). 
The varying dose of PA and different methodology of the PA determination 
make quantitative comparison difficult. Lysine loading tests, however, 
revealed no abnormality in the saccharopine route in both syndromes 
(Gatfield et al, 1968, Burton et al, 1981, Arneson et al, 1982, Trijbels 
et al, 1979). Decreasing intake of protein (1 g/kg/d) was accompanied by 
decreasing serum PA level in two patients (Gatfield et al, 1968, Burton 
et al, 1981), but no apparent effect on the clinical condition of the 
patients was noticed. Thomas et al, 1975, mentioned no effect of a diet 
with 1.25 g protein/kg/d on the serum pipecolic acid concentration. Only 
Gatfield et al (1968) determined the pipecolic acid level in CSF of one 
patient with hyperpipecolic acidemia; he noted an increased level of 1-2 
ymol/l. 
No data concerning the bile acids, organic acids, levels of saturated 
VLCFA and plasmalogen concentrations in ΗΡΑ are available. 
An extensive report of pathologic alterations in ΗΡΑ was published by 
Challa et al (1983). Storage material in astrocytes and satellite cells, 
but not in neurons, was mentioned by Gatfield (1965) and Challa et al 
(1983). Accumulation of 1-1.5 μπι granules with PAS positive, diastase 
resistant, Alcian blue negative, non-lipid, non-fluorescent material was 
noticed. Electron microscopic examination of brain fragments, obtained 
after death, revealed accumulation of multiple membrane-bound vesicles 
of low electron density in the cytoplasm of astrocytes. The origin of 
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these vesicles remains uncertain. The liver tissue of these patients 
showed distinctive intrahepatocytic accumulation of 0.2-1 urn membrane-
bound material of low electron density. The ultrastructural features of 
these membrane-bound structures were granular material of moderate elec­
tron density speckled with minute granules of greater density. The che­
mical nature of the contents of these vacuoles remains unknown. Abundant 
mitochondria, proliferation of smooth endoplasmic reticulum, normal ly-
sosomes and even normal peroxisomes were reported (2 patients) in liver 
tissue (Challa et al, 1983). Burton et al (1981) reported normal peroxi­
somes in one patient. Diffuse moderate tubular dilatation at the corti-
co-medullary junction of the kidneys was reported by Gatfield et al, 
1968. No cortical cysts were mentioned. No ultramicroscopic studies on 
kidney tissue were reported. 
Further investigations of the biochemical and pathologic abnormalities 
of infants suffering from ΗΡΑ will be necessary to delineate whether or 
not this syndrome is identical to Zellweger syndrome. When the presence 
of peroxisomes in liver tissue is confirmed, then ΗΡΑ is a different 
disorder. 
Trihydroxycoprostanic acidemia 
The presence of trihydroxycoprostanic acid (THCA) in the duodenal fluid 
of two unrelated children with intrahepatic bile duct anomalies was 
first reported by Eyssen et al (1972). The presence of DHCA was suppo­
sed. The Zellweger-like appearance of their second patient was mention­
ed. 
Hanson et al (1975) studied two children from one family with cholesta­
sis and increased amounts of THCA in bile, stool, serum and urine. No 
results were reported about PA or plasmalogen metabolism or VLCFA le­
vels. The clinical data however, provided by Hanson et al (1975), sug­
gest a disorder different from CHR-S. Both children died of liver failu­
re, one at the age of 8 months and the other probably at the age of 23-
24 months. Such a clinical course is unusual in CHR-S. Other symptoms 
such as facial dysmorphic features, extreme hypotonia and poor sucking 
were not mentioned. 
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Parmentier et al (1979) described three infants with "coprostanic acide-
mia" with neurological, dysmorphic and cholestatic symptoms of variable 
degree. One of the patients had all the symptoms of the Zellweger syn-
drome. THCA was a major component of the bile acids in bile, serum, uri-
ne and faeces; also considerable amounts of DHCA were found in bile, se-
rum, urine and faeces. A small amount of varanic acid was identified in 
bile. The serum of their three patients contained important amounts of 
3a, 7a, 12a-trihydroxy-5 0-C23 dicarboxylic bile acid, small amounts were 
detected in bile and urine. They noted that the severe clinical expres-
sion of "trihydroxy-coprostanic acidemia" completely corresponds with 
the CHR-S. Recent further investigation of their second patient (J.V. 
II) in our laboratory revealed increased concentration of PA in urine 
and serum and an increased serum level of the saturated VLCFA, strongly 
suggesting the biochemical diagnosis of CHR-S. Their patients J.V. I and 
J.V. II were sibs. Probably the three patients were suffering from the 
CHR-S. 
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ABSTRACT 
The clinical features of 16 patients suffering from cerebro-hepatorenal 
syndrome are presented. Five of these children lived beyond 2 years. 
Four of them are still alive. The increase of plpecolic acid in serum 
and cerebrospinal fluid (CSF), the abnormality of the bile acids and the 
increased excretion of p-OH-phenyl lactate were a consistent finding. 
The concentration of plpecolic acid in urine was not always distinctly 
elevated. A loading test with DL-pipecolic acid was always abnormal. 
KEY WORDS 
Zellweger syndrome - Plpecolic acid - Peroxisomes - Cerebro-hepato-renal 
syndrome 
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INTRODUCTION 
The autosomal recessively inherited cerebro-hepato-renal syndrome was 
first described in 1964 by Bowen et al. (Zellweger syndrome ) (ZS). 
The clinical features, as reported in the literature, are very consis-
tent including severe hypotonia, slow or absent feeding, profound 
psychomotor retardation and a characteristic facial appearance with high 
forehead, epicanthic folds, and large fontanels. The ZS is considered to 
be lethal; death occurs during the first year of life. Biochemically the 
ZS is characterized by disturbances in the metabolism of pipecolic acid 
(Trijbels et al. 1979) and of bile acids (Monnens et al. 1980). Increa-
sed excretion of p-OH-phenyl lactate was also noted (Chalmers et al. 
1980). A defect in the electron transport chain was present in several 
organs tested. Probably all these biochemical abnormalities are due to 
deficiency of peroxisomes in the patients (Goldfischer et al. 1973). 
The purpose of this paper is to present the clinical data of 16 children 
seen in the Netherlands. Four of them are still alive and older than 2 
years. Information will be given about pipecolic acid concentration in 
serum, urine and cerebrospinal fluid (CSF), about the urinary excretion 
of organic acids, and about the bile acids. 
PATIENTS AND METHODS 
Thirteen boys and three girls have been studied. Five of them are still 
alive. Ten of the infants died before the age of 8 months. The other 
child succombed at the age of 2 years and 9 months (see Table 1). D.B. 
and T.B., as well as J.F. and R.F. and R.v.d.L. and S.v.d.L. are sibs. 
Pipecolic acid was measured as described previously (Trijbels et al. 
1979) with some modifications. The standard procedure for amino acid 
analysis was used with lithium citrate buffers. Ninhydrin solution was 
prepared as described but SnCl. was omitted from the solution to prevent 
precipitations in the reaction coil. 
Bile acids were determined as described previously (Monnens et al.1980). 
Organic acids were measured by gaschromatography. 
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RESULTS 
History of the Families 
The eleven sibs and both parents of the reported patients were complete-
ly normal. Consanguinity was present in one family. The parents were 
fourth cousins. Three cousins of B.v.M. died in early infancy. According 
to information obtained from the parents of B.v.M. autopsy findings re-
vealed polycystic kidneys. 
Gestation and Delivery 
The gestational period was normal. All children were normally active in 
utero. The duration of pregnancy was normal. Caesarian section was per-
formed in T.v.M. because of prolonged labour. Vertex delivery occurred 
in the other children. Three infants needed active resuscitation after 
birth. Three children were small for dates; the remainder had a normal 
birth weight. 
Clinical Features (Fig. 1,2) 
The principal features are summarized in Table 2. Hypertelorism is not 
mentioned as a clinical symptom. In 6 children considered to have hyper-
telorism, exact measurement of the inner canthal distance, outer canthal 
distance and interpupillary distance revealed normal values in 5 (Fein-
gold et al. 1974). 
Hypotonia with hyporeflexia or areflexia was present in all patients 
except one: C D . was hypertonic with brisk reflexes. The older children 
become less hypotonic and are able to drink their milk. The nystagmus 
was horizontal, with a rotatory component in some of them. They did not 
follow light. In 4 children the pupillary constriction caused by light 
was present during the first months of life, and disappeared gradually. 
Fundoscopic examination was performed in 11 children. In 8 optic disc 
pallor was observed; in 4 retinal pigmentary changes were present. In 2 
patients small opacities were present in the cornea. In 5 adequately 
tested patients a severe impairment of hearing could be demonstrated. 
Sensory examination revealed no abnormalities. A striking feature was 
the absence of hepatomegaly at birth. Three out of the four oldest 
children developed splenomagaly. 
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Fig. 
I. Patient of 2 months; 
note the hypotonia. 
ig. 2. Note the peculiar 
facies. Fig 
Table 1. Sex, age of death and cause of death of 16 Zellweger patients 
Initials 
E.N. 
D.B. 
T.B. 
J.F. 
R.F. 
B.v.M. 
J.S. 
CD. 
M.d.R. 
T.Ba. 
B.R. 
T.v.M. 
R.v.d.L. 
K.M. 
S.v.d.L. 
M.G. 
Sex 
F 
M 
M 
M 
F 
M 
M 
M 
M 
M 
M 
F 
M 
M 
M 
M 
Age of death 
5.5 months 
5 months 
7 months 
1 week 
5 weeks 
6 months 
Still alive (5 years) 
Still alive (5 years) 
2 9/12 years 
5 weeks 
Still alive (3.5 years) 
Still alive (2.5 years) 
1 month 
3 months 
2 months 
Still alive (4 months) 
Cause of death 
Pneumonia 
Pneumonia 
Pneumonia 
Sudden death 
Pneumonia 
Sudden death 
Pneumonia 
Sudden death 
Pneumonia 
Sudden death 
Sudden death 
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Table 2. Clinical symptoms 
Craniofacial features 
High forehead 
Frontal bossing 
Large fontanel 
Epicanthal folds 
High arched palate 
Shallow supra orbital ridge 
Central nervous system 
Hypotonia 
Seizures 
Poor sucking 
Psychomotor retardation 
Normal sensory examination 
Severe hearing impairment 
Eye symptoms 
Nystagmus 
Cataract, cloudy cornea 
Clumping of pigment at the 
periphery 
Optic disc pallor 
Other symptoms 
Hepatomegaly 
- at birth 
- during the first year of life 
Jaundice after 7 days 
Failure to thrive 
Cryptorchidism 
Pes equinovarus 
Ulnar deviation of the hand(s) 
Simian crease(s) 
Calcific stippling (patellae) 
Our 
patients 
13/15 
6/12 
12/12 
10/12 
6/7 
10/10 
15/16 
12/16 
16/16 
16/16 
7/7 
5/5 
10/11 
2/6 
4/11 
8/11 
0/15 
15/16 
8/16 
14/16 
6/13 
6/16 
5/16 
11/16 
4/10 
Gatfield 
et al. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
Thomas 
et al. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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Laboratory Data 
Initially the liver function tests were always disturbed. As the child-
ren grew older, the levels of the transaminases mostly decreased. In 
Table 3 the concentration of pipecolic acid in urine, serum and CSF is 
presented. The pipecolic acid concentration in serum of controls was 
always below 10 pmol/l and was never detectable in CSF. In 9 out of 9 
tested children we found abnormal bile acids as described earlier (Mon-
nens et al. 1980). In 5 out of 5 patients the analysis of the organic 
acids showed an increased excretion of p-OH-phenyl-lactate (ranging from 
120-400 ymol/mmol creatinine). The excretion of this compound by con-
trols does not exceed 100 ymol/mmol creatinine. No chromosomal aberra-
tions were detected in 8 out of 8 patients. 
Special Neurologic Examinations 
All the electroencephalograms are considered to be abnormal with spike 
foci and sharp wave discharges. Echograms showed an enlargement of both 
ventricles in 5 out of 9 infants. In three infants a normal electromyo-
gram was observed. 
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Table 3. The concentration of pipecolic acid In urine, serum and cerebrospinal fluid 
Patient 
E.N. 
D.B. 
T.B. 
R.F. 
B.v.M. 
J.S. 
CD. 
M.d.R. 
T.Ba. 
B.R. 
T.v.M. 
R.v.d.L. 
S.v.d.L. 
M.G. 
Age 
5 months 
3 months 
10 days-7 months 
0-1 month 
2.5-5 months 
23/12-26/12 years 
6 months-4 /12 years 
3 months 
3-5 weeks 
8 months-2 /12 years 
2.5-5 months 
4 weeks 
2-6 days 
2 weeks-4 months 
Urine 
(umol/l) 
698 
134 
68-306 
143-168 
81-390 
67-344 
75- 88 
39 
143-158 
6- 52 
10- 28 
311 
39- 82 
75-137 
Urine 
(pmol/g 
creatinine) 
3357 
1819 
588-1779 
1215 
1142-2138 
118-1357 
476- 541 
86 
1402-1663 
9- 220 
79- 91 
3440 
176- 386 
474- 811 
Serum 
(umol/l) 
-
24- 33 
-
43-384 
462 
207 
109 
21- 23 
122-321 
84-182 
-
5.1 
10- 80 
CSF 
(ymol/l) 
-
2.1 
-
0.6-2.9 
6.6 
2.1 
-
-
2.3-4.7 
3.2 
-
9.6 
1.2 
DISCUSSION 
As yet death is considered to occur invariably during the first year of 
life in patients with ZS. However, 5 children in our series were older 
than 2 years and four are still alive. Two older patients described in 
the literature as hyperpipecolatemia are in our opinion also suffering 
from ZS (Gatfield et al. 1968; Thomas et al. 1975). Both children were 
extremely hypotonic, had feeding problems, psychomotor retardation, 
horizontal nystagmus, abnormal discs and retinal changes, and hepatome-
galy. Craniofacial abnormalities are not mentioned by Gatfield et al. 
(1968), frontal bossing was present in the patient reported by Thomas et 
al. (1975). Autopsy findings showing demyelination and gliosis of the 
brain and severe fibrosis of the liver in the patient of Gatfield (1968) 
are In agreement with the findings in ZS (Gilchrist et al. 1975, 1976). 
Recently 2 male siblings with hyperpipecolic acidemia were described by 
Burton et al. (1981). The clinical manifestations closely resembled 
those observed in the ZS. Electron microscopic studies, however, confir-
med the presence of hepatic peroxisomes. Peroxisomes could be difficult 
to identify and reduced in number in ZS (Carlson and Weinberg 1978; 
Pfeifer and Sandhage 1979). It would be very important to demonstrate a 
biochemical disturbance of the peroxisomes in the 2 male siblings and an 
analysis of the bile acids would also be required (Hanson et al. 1979; 
Monnens et al. 1980; Pedersen and Gustafsson 1980). 
In 2 infants suffering from cerebro-hepato-renal syndrome, Chalmers et 
al. (1980) found an increased excretion of 4-hydroxy phenyl-lactic acid 
and dicarboxylic aciduria. 
In 5 patients out of 5 we could confirm the increased excretion of 4-hy-
droxy phenyl-lactic acid. In one of them dicarboxylic aciduria was also 
present. He was, however, receiving a MCT-diet (medium- chain triglyce-
rides-diex), which could explain the dicarboxylic aciduria (Mortensen 
and Gregersen 1980). Pipecolic acid was found in all urine, serum and 
CSF samples tested (Danks et al. 1975). A wide range of the pipecolic 
acid excretion in urine was found in the 13 patients tested: 9-3440 
pmol/g creatinine. The excretion also varied markedly within several in-
dividual patients, whereas others showed a rather constant excretion of 
pipecolic acid. It is doubtful whether all patients showed increased 
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excretion of plpecollc acid. The values given for patients M.d.R. and 
T.v.M. are in the normal range (exact values for controls are collected 
in our clinic). The same holds for patient B.R., who showed once (at the 
age of 2 /12 years) an excretion of only 9 ymol/g creatinine which can 
hardly be considered as increased. All serum samples of the patients in-
vestigated showed increased concentration of plpecollc acid, ranging 
from 5.1-462 pmol/l. The same is true for CSF. The concentration of pl-
pecollc acid varies from 0.6-6.6 ymol/l. Therefore, investigation of 
serum and CSF on pipecolic acid concentration is a better diagnostic 
criterion for screening of patients suspected from ZS. Loading tests 
with DL-pipecolic acid in 8 patients were always abnormal (Trijbels et 
al. 1979). 
Bile acid analysis can confirm the diagnosis in suspected infants. The 
biochemical abnormalities as yet reported in ZS can probably be related 
to the absence of the peroxisomes or disturbance of the peroxisomal 
function (Goldfischer et al. 1973; Pfeifer and Sandhage 1979; Müller-
Höcker et al. 1981; Trijbels et al. 1981). 
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ABSTRACT 
The aim of this study was to describe the EEC's, brainstem auditory evo-
ked potentials and somatosensory evoked potentials obtained in eleven 
children with the Zellweger syndrome. In six out of the eleven patients 
BAEP's and in five of them SSEP's were performed. Severe abnormalities 
could be demonstrated, reflecting diffuse cerebral dysfunction as well 
as long myelinated fiber tracts dysfunction. In four of six patients no 
response was obtained by BAEP's and in two the central conduction time 
was delayed. The specific (until 60 ms) and aspecific (after 60 ms) com-
plex of the SSEP'S was delayed or the potential could not be elecited. 
During sleep as well as wakefulness characteristic abnormalities of the 
EEC's were found in nine patients. These abnormalities consisted of con-
tinuous negative sharp waves and spikes at the vertex. 
KEYWORDS 
Cerebro-hepato-renal syndrome of Zellweger (CHR-S), evoked potentials 
(EP), EEC. 
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INTRODUCTION 
The clinical features of the autosomal recessive inherited cerebro-hepa-
to-renal syndrome (CHR-S) are very consistent. These symptoms are severe 
hypotonia, profound psychomotor retardation and a characteristic facial 
appearance with a high forehead, epicanthic folds and large fontanels 
(Fig. 1). Most of the patients develop tonic clonic seizures in early 
infancy. The increase of pipecolic acid in serum and cerebrospinal 
fluid, the abnormality of the bile acids, the increased excretion of 
p-OH-phenyllactate, the abnormal long chain fatty acid pattern in plas-
ma, and a decreased level of plasmalogens in tissues are consistent fin-
dings in this syndrome (Trijbels et al, 1979, Monnens et al, 1980, Go-
vaerts et al, 1982, Heymans et al, 1983, Bakkeren et al, accepted 1984). 
Although the CHR-S is considered to be lethal during infancy, four of 
our patients are still alive and in excess of two years. Six patients 
demonstrated a severe hearing impairment. The pupillary constriction 
caused by light was present during the first months of life and disap-
peared gradually for four children. Eight out of eleven patients showed 
optic disc pallor, and four of them exhibited clumping of pigment at 
the retinal periphery. Sensory examination, as far as tested, revealed 
no abnormalities. The severe psychomotor retardation made detailed 
sensory examination impossible. 
The patients explored their surroundings with their hands, and preferred 
smooth toys. Pain stimuli caused a reaction of crying and withdrawal. 
Ultramicroscopic and biochemical studies have revealed deficiency of 
peroxisomes and mitochondrial abnormalities (Goldfischer et al, 1973, 
Trijbels et al, 1981, Trijbels et al, 1983) in CHR-S. 
The aim of the study was to investigate the neurophysiologlcal aspects 
of CHR-S. To our knowledge this area has not yet been reported. 
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Fig. 1: Note the peculiar facies. 
SUBJECTS AND METHODS 
Subjects 
The initials, age, and different studies as performed in our patients 
are shown in Table I. An EEG was available in all children. Only in 
children of recent years, after the technique was well established, were 
brainstem auditory evoked potentials (BAEP) and somato-sensory evoked 
potentials (SSEP) performed. 
Table I: The patients, their age, and the different studies performed. 
Patient 
E.N. 
D.B. 
T.B. 
B.v.M 
J.S. 
CD. 
T.Ba 
B.R. 
T.v.M 
M.G. 
W.G. 
Age 
1/12 
4/12 
3/12 
4/12 
1/12 
2/12 
4/12 
4 2/12 
6/12 
4 6/12 
1/12 
7/12 
1 9/12 
2 
2 6 /12 
6/12 
2 
3/1 
1 3/12 
1 4/12 
EEG 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
-
+ 
-
+ 
BAEP 
-
-
-
-
-
-
-
+ 
-
+ 
-
-
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
SSEP 
-
-
-
-
-
-
-
+ 
-
+ 
-
-
-
+ 
-
-
-
+ 
+ 
-
+ = performed I - - not performed / age in years 
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Methods 
The EEG-electrodes were positioned according to the international 10-20 
system. The recordings were obtained during wakefulness and sleep with 
photic stimulation (on Elema Schönander mingograf). 
For the BAEP registration, Nicolet C.A.-1000 was used, with monoaurally 
click stimulation of 0,1 msec duration, 80 dB, 11,1/s, (± 2000 stimuli). 
Ag/AgCl discelectrodes preauricular (pA), with F as active and pAj or 
pA, as reference electrode were used to record the EP, bandpass between 
30 and 3000 Hz (3 dB down, rolling off at 12 dB/octave). 
The SSEP's were obtained by means of 0,1 msec electrical stimulation, 
twitch level, on the right median nerve at the wrist. Ag-AgCl electrodes 
were positioned in between C- and P, with the reference electrodes on 
pA.. For the specific EP components (until 60 ms) 3 Hz regular stimula-
tion with a bandpass of 5 to 500 Hz (3 dB down, rolling off at 12 dB/oc-
tave) was used and for the aspecific (after 60 ms) EP components 1/3 Hz 
at random stimulation with bandpass of 1 to 250 Hz (3 dB down, rolling 
off at 12 dB/octave) was used. To test the reproducibility each trial 
was performed twice. 
Sample frequency for the specific components was 2560 Hz and for the 
aspecific components 512 Hz. The resistance of the electrodes was always 
kept well below 3000 Ohn. For the specific components at least 1000 tra-
ces and for the aspecific components at least 100 traces were averaged 
in each trial. Latencies of all EP's were determined by measurements 
with an electronic cursor. 
RESULTS 
1) EEC's 
All the electroencephalograms except one (W.G.), were considered to be 
abnormal with spike foci and sharp wave discharges (Table II). Discharges 
at the vertex are seen in nine of eleven children, consisting out of 
frequent negative spikes or sharp waves during sleep as well as during 
wakefulness (Fig. 2). No photic driving could be obtained in any of the 
children (16 EEC's). 
116 
Table II: EEG findings of the patients at different ages. 
Patient 
E.N. 
D.B. 
T.B. 
B.v.M. 
J.S. 
CD. 
T.Ba. 
B.R. 
T.v.m. 
M.G. 
W.G. 
Age 
years 
1/12 
4/12 
3/12 
4/12 
1/12 
2/12 
4/12 
4 2/12 
6/12 
4 6/12 
1/12 
7/12 
2 
6/12 
3/12 
1 4/12 
Abnormal 
background 
activity 
+ 
+ 
-
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
Diffuse 
epileptiform 
activity 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
Epileptiform 
configuration 
above the vertex 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
+ 
-
+ 
+ 
+ 
-
Photic 
driving 
-
-
-
-
-
-
-
-
-
-
-
-
-
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Fig. 2a: An example of EEG findings in children with the Zellweger 
syndrome. The child is awake. Note the vertex sharp waves and 
spikes, indicated by an arrow. 
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• ч _ 
Fig. 2b: An example of EEG findings in children with the Zellweger 
syndrome. The child is in a quiet sleep. Note the vertex sharp 
waves and spikes, indicated by an arrow. 
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2) BAEP's - SSEP's 
The findings of BAEP's and SSEP's are summarized in Table III. An exam-
ple of a normal and abnormal BAEP is given in Fig. 3 and of a normal and 
abnormal SSEP is given in Fig. 4. In most of them no response was obtai-
ned by BAEP (Table III). In two patients the central conduction time 
(I-V latency) was delayed (CD. and T.v.M.). 
In five children SSEP's could be applied. The SSEP components after 60 
ms were in all patients limited to C,1 area which is in contrast with 
the findings in normal children (see Fig. 4). There seems to be a inter-
hemispheric propagation disturbance. The specific complex was delayed in 
four of five registrations indicating a propagation defect, between the 
wrist and the cortex, (Fig. 3, Table III). Sensory and motor nerve con-
duction velocity was normal (B.R., T.v.M., W.G.). 
3) echo encephalography - CT scan 
Every patient, except one (E.N.)» had a slightly increased T/D index 
(Krijgsman, 1977), two (B.v.M. and B.R.) out of three patients showed an 
increasing T/D index during follow up suggesting increased central atro-
phy. 
The defective myelination could not be demonstrated by CAT-scan density 
abnormalities in C D . (6/12 years old), B.R. (7/12), T.v.M (4/12) and 
W.G. (1 4/12). Vermis aplasia was noted in C D . 
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Table III: BAEP's - SSEP's. 
Patient 
J.S. 
CD. 
B.R. 
T.v.M. 
M.G. 
W.G. 
age 
(years) 
4 2/12 
4 6/12 
1 9/12 
2 
2 6/12 
6/12 
2 
3/12 
1 9/12 
1 4/12 
B.A 
right 
-
C C T . 
delayed 
-
-
-
-
-
-
-
.E.P. 
left 
-
C C T . 
delayed 
-
-
-
C C T . 
delayed 
-
-
? 
-
S.S.E.P. 
delay specific 
complex 
++ 
+ 
N.P. 
+ 
N.P. 
N.P. 
'N.P. 
-
+ 
N.P. 
delay aspecific 
complex 
-
-(?) 
N.P. 
+ 
N.P. 
N.P. 
N.P. 
-
+ 
N.P. 
interhemipheric 
propagation defect 
* 
* 
N.P. 
* 
N.P. 
N.P. 
N.P. 
-
* 
N.P. 
C C T . » central conduction time 
» not elicitable 
+ = slightly delayed (p <0,05) 
++ = severe delayed (p <0,01) 
specific complex between median nerve at the wrist and cortex 
N.P. = not performed 
* - present 
Specific complex, aspecific complex and C.C.T.: according to Colon et al, 1983. 
I II III IV ν 
t t t t t 
R+R 
R + R 
Normal 
CHR-S 
Stimulus 
Fig. 3: Example of a normal BAEP (upper three traces) and of a BAEP from 
one of the CHR-S patients, after right ear stimulation. 
I until V are the different components which can only be seen in 
the normal traces. 
R = right preauricular derivation (other on F ). 
L = left preauricular derivation (other on F J. 
The BAEP was elicited twice which is represented at the lower 
traces ( R + R ) . 
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Fig. A: Example of a normal (upper three traces) and an abnormal SSEP 
derived from С ' С ' and С ' (pA reference) after median nerve 
stimulation of a Zellweger patient (lower three traces). 
Some components are indicated. Note the very restricted locali­
zation of the components after 60 ms in the patient. 
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DISCUSSION 
The diagnosis of all these patients was based on clinical features and 
laboratory findings according to Govaerts et al, 1982. 
Symptoms of the visual system were already present in the neonatal pe-
riod. These consisted of a horizontal nystagmus (ten of eleven patients) 
and inability to follow light. In six children who survived to six 
months of age, the pupillary constriction due to light, which was pre-
sent during the first months of life, disappeared gradually. 
In six adequately tested patients a severe impairment of hearing was de-
monstrated. There was no recognizable reaction by free field audiometry 
up to 70 dB. An electro-cochleography was not performed because of the 
high risk of anesthesia in these infants. Profound psychomotor retarda-
tion was always present. Our oldest patient is six years old and unable 
to sit without support. Tactile contact is observed. Affected indivi-
duals smile if they feel comfortable. Sudden death occurred in four of 
the eleven children and three died due to pneumonia. Four children are 
alive and older than two years. 
The neuropathologic findings consisted of cortical dysplasia (islands of 
ectopic neurones), dysmyelination throughout the CNS and the spinal 
cord, and accumulation of neutral fat in histiocytes in the white and 
gray matter of cerebrum, cerebellum and in the basal ganglia (Passarge 
et al. 1967, Liu et al, 1976, Agamanolis et al, 1979, Müller-Höcker et 
al, 1981, Della Giustina et al, 1981). These symptoms are considered 
characteristic of this syndrome (Agamanolis et al, 1979). 
The severe hearing impairment prompted us to record the BAEP's. Except 
in C D . and T.v.M. these were not elicitable. 
The SSEP's were elicitable but only with a delayed conduction. Nearly 
every EEG showed abnormal background activity and epileptiform confi-
guration. These data suggest a severe diffuse cerebral dysfunction, 
especially of the white matter in the brain. 
The SSEP's point towards a severe propagation dysfunction over the mye-
linated pathways. The electrocerebral information from the sense organs 
(peripheral nerve) was not adequately transported through the central 
nervous system. We are dealing, therefore, with a form of leukodystrophy 
124 
(Gloor et al, 1968, Starr et al, 1976, Colon et al, 1979, Gracco et al, 
1980, Markand et al, 1982). The CAT-scan however could not reveal the 
deficient myelination. The clinical neurophyslological studies were more 
informative. This leukodystrophy is severe since some BAEP's are delayed 
while SSEP conduction is seriously disturbed, probably of the interhemi-
spheral fibers (the interhemispheric SSEP propagation in all examined 
patients is disturbed). 
Another interesting finding was the fact that almost all patients with 
CHR-S show spike or sharp waves above the vertex in the EEG. Sharp 
vertex activity is described in stage II sleep and as an arousal reac-
tion after acoustic stimulation (Samson et al, 1961).In our group the 
EEG phenomena are seen continuously in sleep as well as during wakeful-
ness. The mechanism producing such midline spikes is uncertain (Nelson 
et al, 1983). 
In other forms of leukodystrophy different EEG abnormalities are des-
cribed. In the metachromatic type the EEG initially remains normal. 
Later the EEG contains beta activity in the anterior or posterior re-
gions (Pampiglione, 1968). In Krabbes disease, Pampiglione (1968) found 
more profound abnormalities, even irregular slow activity with sharp 
waves and occasional spikes. None of these EEG patterns are comparable 
which the abnormalities seen in our patient group. Therefore, it is 
possible that negative spiking (or sharp waves) In the vertex region 
combined with these EP abnormalities is rather characteristic for the 
CHR-S. 
SUMMARY 
EEC's, BAEP's and SSEP's of children with the CHR-S of Zellweger are 
described. Diffuse cerebral dysfunction could be demonstrated. Rather 
characteristic abnormalities of the EEC's were found. 
125 
REFERENCES 
Agamanolis, D., Robinson, H., Timmons, D.: Cerebro-hepato-renal syndro-
me, report of a case with histochemical and ultrastructural observa-
tions. J. Neuropath, exp. Neurol., 1976, 35: 226-246. 
Agamanolis, D., Pâtre, S.: Glygogen accumulation in the central nervous 
system in the cerebro-hepato-renal syndrome. Journal of the Neurological 
Sciences, 1979, 41: 325-342. 
Bakkeren, J., Monnens, L., Trijbels, J., Maas, J.: Serum very long chain 
fatty acid pattern in Zellweger syndrome. Clin Chim Acta, 1984, 138: 
325-331 
Colon, E., Renier, W., Cabreéis, F.: Propagation defects in somato sen-
sory evoked responses in children. In: H. Lechner and A. Aranilar (Eds): 
EEG and clinical neurophysiology, Elsevier, North Holland, 1979, pp 306-
313. 
Colon, E., Visser, S., de Weerd, J., Zonneveldt, Α.: Evoked potential 
manual. Martinus Nijhoff Publishers, 1983, pp. 121-128 and 268-270. 
Gracco, J., Bosch, V., Gracco, R. : Cerebral and spinal somatosensory 
evoked potentials in children with CNS degenerative disease. EEG and 
Clin. Neurophys., 1980, 49: 437-445. 
Danks, D., Tippett, P., Adams, C , Campbell, P.: Cerebro-hepato-renal 
syndrome of Zellweger. J. Pediatr, 1975, 86: 382-387. 
Della Giustina, E., Goffinet, Α., Landrieu, P., Lyon, G.: A Golgi study 
of the brain malformation in Zellweger's cerebro-hepato-renal disease. 
Acta Neuropathol. (Beri), 1981, 55: 23-28. 
Gloor, P., Kalabay, D., Giard, M. : The electroencephalogram in diffuse 
encephalopathies: electroencephalograhlc correlates of grey and white 
matter. Brain, 1968, 91: 779-802. 
Goldfischer, S., Moore, С , Johnson, Α., Spiro, Α., Valsarais, Μ.: Per­
oxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. 
Science, 1973, 182: 62-64. 
Govaerts, L., Monnens, L., Tegelaers, W., Trijbels, J., and van Raay-
Selten, Α.: Cerebro-hepato-renal syndrome of Zellweger: clinical symp­
toms and relevant laboratory findings in 16 patients. Eur. J. Pediatr., 
1982, 139: 125-128. 
Krijgsman, J.: Echo-encephalographic measurements (Α-scan) of the late­
ral ventricles in children; its reliability. Clin. Neurol. Neurosurg., 
1977, 80: 1-9. 
Liu, H., Bangaru, В., Kidd, J., Boggs, J.: Neuropathological considera­
tions in cerebro-hepato-renal syndrome (Zellweger's syndrome). Acta Neu­
ropath. (Beri.), 1976, 34: 115-123. 
126 
Markand, 0., Garg, В., De Meyer, W., Warren, C. and Worth, R.: Brainstem 
auditory, visual and somatosensory evoked potentials in leukodystro­
phies. EEG and Clin. Neurophys., 19Θ2, 54: 39-48. 
Monnens, L.,Bakkeren, J., Parmentier, G., van Haelst, U., Trijbels, F., 
Eyssen., H.: Disturbances in bile acid metabolism of infants with the 
Zellweger (cerebro-hepato-renal) syndrome. Eur. J. Pediatr., 1980, 133: 
31-35. 
Müller-Höcker, J., Bise, К., Endres, W., Hübner, G.: Zur Morphologie und 
Diagnostik des Zellweger Syndroms. Virchows Arch. (Pathol, anat.), 1981, 
93: 103-114. 
Nelson, K., Brenner, R., de la Paz, D.: Midline spikes: EEG and clinical 
features. Arch. Neurol., 1983, 40: 473-476. 
Ochs, R., Markand, 0., De Meyer, W.: Brainstem auditory evoked responses 
in leukodystrophies. Neurology, 1979, 23: 1089-1093. 
Pampiglione, G.: Some inborn metabolic disorders affecting cerebral 
electrogenesis. In Holt, K.S. and Coffrey, V.P.(Eds): Some recent advan-
ces in inborn errors of metabolism, Edinburgh, Livingstone, 1968, ρ 
89-91. 
Passarge, E., McAdams, Α.: Cerebro-hepato-renal syndrome. J. Pediatr., 
1967, 71: 691-702. 
Samson, D., Samson, M.: Transduction électroencephalographique des reac-
tions d'éveil chez l'enfant. Exc. Med. Int. Congr. Series, 1961, 37: 
60-61. 
Starr, Α., Hamilton, Α.: Correlation between confirmed sited of neurolo­
gical lesions and abnormalities of far-field brainstem responses. EEG 
and Clin. Neurophys., 1976, 41: 595-608. 
Trijbels, J., Monnens, L., Bakkeren, J., van Raay-Selten, Α.: Biochemi­
cal studies in the cerebro-hepato-renal syndrome of Zellweger: a distur­
bance in the metabolism of pipecolic acid. J. Inher. Metab. Dis., 1979, 
2: 39-42. 
Trijbels, J., Monnens, L., Bakkeren, J., Willems, H., Sengers, R.: Mito­
chondrial abnormalities in the cerebro-hepato-renal syndrome of Zellwe­
ger. In: Busch, H., Jennekens, F., Schölte, H. (eds). Mitochondria and 
muscular diseases. Mefar b.v.. The Netherlands, 1981, pp 187-190. 
Trijbels, F., Berden, J., Monnens, L., Willems, J., Janssen, Α., Schut­
gens, R. and van den Broek-van Essen, M.: Biochemical studies in the 
liver and muscle of patients with Zellweger syndrome. Pediatr. Res., 
1983, 17: 514-517. 
127 

CHAPTER V 
DISTURBED ADRENOCORTICAL FUNCTION 
IN CEREBRO-HEPATO-RENAL 
SYNDROME OF ZELLWEGER 
L. Govaerts, L. Monnens, T. Melis, F. Trijbels 
University of Nijmegen, Department of Paediatrics, Nijmegen, 
The Netherlands 
Accepted for publication: Eur J Pedlatr, 16th May 1984 
ABSTRACT 
An ACTH stimulation test was performed in six patients suffering from 
the cerebro-hepato-renal syndrome of Zellweger. In contrast to controls, 
no rise in Cortisol was observed. None of these patients showed clinical 
symptoms of adrenal insufficiency. The sudden death, which occurs in 
this syndrome, can probably be explained by an impaired stress reaction. 
In stress situations, such as respiratory infection, corticosteroids 
should be administered to these patients. 
A striking resemblance exists between the Zellweger syndrome and the 
neonatal form of adrenoleukodystrophy. 
KEY WORDS 
cerebro-hepato-renal syndrome (CHR-S), Zellweger syndrome, adrenal func-
tion, adrenoleukodystrophy (ALD) 
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INTRODUCTION 
The autosomal recessively inherited cerebro-hepato-renal syndrome of 
Zellweger (CHR-S) was first described in 1964 by Bowen et al (5). It is 
considered to be lethal. Death may occur in early infancy (11,13). 
The known biochemical abnormalities include: increased concentration of 
pipecolic acid in serum, urine and cerebrospinal fluid, abnormal bile 
acid pattern in duodenal fluid, serum and urine, increased excretion of 
p-OH-phenyllactate in urine (11), disturbances in the electron transport 
chain (8,24), deficiency of plasmalogens in tissues (12) and an eleva-
tion of the saturated very long chain fatty acid content in serum (6,2), 
brain white matter, adrenal gland and cultured fibroblasts (6). The va-
rious biochemical abnormalities of CHR-S can probably be related to the 
absence of peroxisomes or disturbance of the peroxisomal function (24). 
In adrenoleukodystrophy (ALD) similar abnormalities of the very long 
chain fatty acids were described (16). An elevated content of C26 fatty 
acids was reported in cultured skin fibroblasts (16), in plasma (17), in 
adrenal gland (23), in leukocytes (15) and in cultured amniocytes and 
fetal adrenal gland (18). 
The neonatal form of ALD, an autosomal recessive disease, has in addi-
tion a striking clinical resemblance to CHR-S (4,6). Absence of peroxi-
somes in the neonatal ALD was reported by Partin and McAdams (19). 
As the adrenocortical function is disturbed in ALD it was tempting to 
investigate this function in CHR-S. It is the aim of this report to pre-
sent these results. 
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PATIENTS AND METHODS 
Patients 
Six patients suffering from the CHR-S were investigated. None of these 
infants had clinical adrenal insufficiency. Hyperpigmentation of the 
skin was absent. No electrolyte disturbances were present. The diagnosis 
Zellweger syndrome was based on the clinical features and biochemical 
abnormalities (11). Informed consent was obtained from the parents. 
Methods 
The ACTH stimulation test was performed at 9.00 a.m. 
Synacthen (0.150 mg/m2) was given intravenously and blood samples were 
collected 0, 30 and 60 min after injection. The Cortisol concentration 
was determined by radio immuno assay (Clinical Assays, coated tubes). 
RESULTS 
The Cortisol levels 0, 30 and 60 min after injection of Synacthen into 
six patients and three controls are given in Table I. No increase in the 
Cortisol level was observed in CHR-S patients while an adequate reaction 
of Cortisol was seen in the controls (3). 
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Table I: Cortisol levels (umol/l) 0, 30 and 60 min after 
intravenous administration of 0.150 mg/m2 Synacthen. 
Subjects 
Patient CD. 
B.R. 
T.v.M. 
M.G. 
т.е. 
J.V. 
Controls: 1 
2 
3 
Time 
0 
0.36 
0.46 
0.39 
0.36 
0.44 
0.48 
0.66 
0.56 
0.34 
30 
0.30 
0.40 
0.41 
0.50 
0.57 
1.06 
1.00 
0.62 
60 
0.32 
0.38 
0.41 
0.38 
0.50 
0.56 
1.28 
1.18 
0.88 
Normal basal Cortisol level at 9.00 a.m.: 
0.25-0.70 nmol/l. 
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DISCUSSION 
An inadequate response to ACTH injection was observed in all patients 
investigated, indicating a primary (partial) adrenocortical insufficien-
cy. Sudden death occurred in 7 out of 17 patients known to us, while 6 
of them expired from a pneumonia. Adrenal failure could have been an im-
portant contributing factor in their death. We recommend the use of cor-
ticosteroids in stress situations. The same abnormality of adrenocorti-
cal function is observed in the different forms of ALD (22,4). 
The pathogenesis of this adrenal insufficiency remains unclear. In his-
tologic studies striated adreno-cortical cells of the reticularis-inner 
fasciculata layer were described in patients with CHR-S and in ALD. The-
se cells contained lamellae and lamellar-lipid profiles of very long 
chain fatty acids-cholesterol esters (10). The saturated very long chain 
fatty acids could be cytotoxic and responsable for the adrenocortical 
dysfunction (20). Measurements of fluorescence polarisation demonstrated 
a highly significant increase in the microviscosity of erythrocyte mem-
branes in ALD (14). Experimental data in animals point to a correlation 
between membrane microviscosity and the number of hormone receptors in 
target tissues. Therefore Knazek et al (14) proposed that the decrease 
in responsiveness to trophic hormone is secondary to change in the mem-
brane microviscosity of the adrenal gland. Cells of the guinea pig adre-
nal cortex contain numerous small peroxisomes. These peroxisomes possess 
a high activity for long chain fatty acid g-oxidation. The acetyl-CoA, 
generated as a result of the peroxisomal g-oxidation, could be directed 
to the synthesis of cholesterol, the precursor of the adrenal steroids 
(21). Especially after stimulation by ACTH, the amount of acetyl-CoA 
could be rate-limiting, when the peroxisomal contribution is absent, as 
in CHR-S. Several authors have already mentioned similarities between 
the neonatal ALD and the CHR-S. Both have the same mode of inheritance 
and the same clinical features. Patients can succumb at early age (4). 
Pathologic studies reveal the same abnormalities: Agamanolis et al (1) 
noticed a similarity between the cytoplasmic inclusions (multilamellar 
bodies) of macrophages, Oligodendroglia! cells and astrocytes of the ce-
rebrum of Zellweger patients and the inclusions seen in the adrenals, 
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Schwann cells, testis and brain of cases with ALD. The lamellar-lipid 
profiles, considered to be diagnostic for neonatal ALD were found by 
Goldfischer et al (10), in the adrenal glands of eight patients with 
Zellweger syndrome. Ocular histopathologic studies demonstrated that the 
CHR-S and neonatal ALD are similar with regard to ocular abnormalities 
(7). In addition increased levels of saturated very long chain fatty 
acids in fibroblasts (6), serum (6,2), and several tissues (6,10,7) were 
reported. In CHR-S the adrenal cortical insufficiency is a new feature, 
already known in ALD. The question arises whether these disorders are 
different or not. The absence of hepatic peroxisomes in the neonatal 
form of ALD recently described by Partin and McAdams (19) supports the 
hypothesis that both diseases have a common cause. To answer this ques-
tion other biochemical studies are recommended on the neonatal ALD, es-
pecially analysis of the bile acids, the pipecolic acid level in serum, 
cerebrospinal fluid and urine and of plasmalogens. 
Acknowledgements: We are grateful to Prof.Dr.E. Eggermont and Dr.J. 
Jaeken from the Department of Paediatrics of the Catholic University of 
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SUMMARY 
The very long chain fatty acids in cultured fibroblasts from six pa-
tients with the cerebro-hepato-renal syndrome of Zellweger, from six of 
their parents, from three controls, and also in three amniotic fluid 
control cell lines were analyzed by gas chromatography. 
Increased concentrations of hexacosanoic acid (C26:0) were consistently 
found in the Zellweger syndrome. Also the ratios C26:0/C22:0, C25:0/ 
C22:0, and C24:0/C22:0 were elevated. The very long chain fatty acid le-
vels and ratios in fibroblasts from the patients' parents were within 
the normal range. Findings in amniotic fluid cell lines indicate the 
possibility of antenatal diagnosis for the Zellweger syndrome. The simi-
larities between neonatal adrenoleukodystrophy and Zellweger syndrome 
suggest the applicability of this technique also in neonatal adrenoleu-
kodystrophy. 
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INTRODUCTION 
The autosomal recessively inherited cerebro-hepato-renal syndrome of 
Zellweger (CHR-S) (McKusick * 2 Ш 0 ) is characterized by dysmorphic 
features, several biochemical abnormalities and in 90% of the cases 
death during infancy (Govaerts et al 1982). The absence of peroxisomes 
in liver tissue and in proximal tubules of the kidney (Goldfischer, 
1973) has been brought into relation with the reported biochemical ab­
normalities. Such a relationship has been strongly suggested for the 
abnormal bile acid metabolism (Pedersen and Gustafsson, 1980), the de­
fect in pipecolic acid metabolism (Trijbels et al, 1979 and 1981), the 
disturbance in the electron transport chain (Trijbels et al, 1983), the 
deficiency of plasmalogens (Heymans et al, 1983), and the increased le­
vels of very long chain fatty acids (C24-C26) in serum (Bakkeren et al, 
1984), in brain white matter, adrenal gland and cultured fibroblasts 
(Brown et al, 1982). 
In the X-linked adrenoleukodystrophy (ALD) of childhood (McKusick 
* 30010), a disorder involving predominantly the white matter of the 
central nervous system and the adrenal cortex (Schaumburg et al, 1975), 
similar increased very long chain fatty acid levels were found in plasma 
(Moser et al, 1981) and in cultured fibroblasts (Kawamura et al, 1978, 
Moser H et al, 1980A). By determining the very long chain fatty acid 
levels and ratios in plasma and fibroblasts, identification of female 
carriers of childhood ALD is possible in 93% of women who are obligate 
heterozygotes (Tönshoff et al, 1982, Moser et al, 1983). Moser et al 
(1982) described the possibility of prenatal diagnosis of childhood ALD 
by application of this method on amniotic fluid cells. 
The neonatal ALD (McKusick 20237), an autosomal recessive disease, has a 
striking clinical resemblance to CHR-S (Benke et al, 1981, Brown et al, 
1982). The accumulation of very long chain fatty acids was reported in 
brain tissue (Manz et al, 1980), in plasma, adrenal gland and in skin 
fibroblasts (Brown et al, 1982). Absence of peroxisomes in neonatal ALD 
was reported by Partin and McAdams (1983) in liver tissue. 
The present study on fibroblasts from Zellweger patients and their pa-
rents, and on control fibroblasts and amniotic fluid cells, was perfor-
med to explore the possibilities of antenatal diagnosis and heterozygote 
detection for this disease. 
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PATIENTS AND METHODS 
Patients 
Six children suffering from the CHR-S were investigated. Six parents of 
Zellweger patients were included in the study. The clinical and relevant 
biochemical abnormalities have been described earlier (Govaerts et al, 
1982). Patients M.S. and N.v.d.E. fulfilled also all diagnostic crite­
ria. 
Methods 
Fibroblasts were obtained by skin biopsy and grown in a 5% carbon dioxi­
de atmosphere at 37°C in TC-199 with Earle's salts and 20% fetal calf 
serum (FCS) (or 10% fetal plus 10% newborn calf serum in later passa­
ges). Amniotic fluid cells were obtained by amniocentesis performed in 
pregnancies not at risk for CHR-S or ALD. Cells were cultured in the 
same way as the fibroblasts. The cells were harvested with 0.25% trypsin 
after having reached confluence. After washing twice with phosphate-buf­
fered saline (PBS) plus 10% FCS and twice with cold PBS, 5 χ 10 cells 
were disrupted by freezing and thawing once. Heptadecanoic acid (C17:0) 
(0.2 mol) was added to the homogenate as an internal standard. Lipids 
were extracted with chloroform/methanol (1:1, v/v), transmethylated with 
1.5 mol/1 HCl in methanol at 750C for 16 h, and the methyl esters ex­
tracted into hexane and analyzed by capillary gas chromatography as 
described previously (Bakkeren et al, 1984). All peaks corresponding to 
fatty acids were identified by their retention times and quantitated by 
integration. Results were expressed as percentages of total fatty acids 
(C14:0 to C26:0). 
The identity was confirmed by gas chromatography-mass spectrometry 
(GC-MS). For GC-MS a 5995 A instrument (Hewlett Packard, Palo Alto, CA, 
USA) was used, equipped with a 25-m open-tubular fused silica column 
with chemically bounded phase Sil 8 CB (Chrompack, Middelburg, The 
Netherlands). The carrier gas was helium. The oven temperature was at 
first 44° C, after 1 min raised to 180° С and then programmed to 290oC 
at 8° С per min. Chromatography was carried out in the splitless mode. 
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The ion source temperature was 180° C, the transferline temperature was 
300° С The electron energy was 70 eV. Electron impact mass spectra were 
recorded. Selected ion monitoring was used for identifying the different 
very long chain fatty acids. 
RESULTS 
The levels and ratios of the very long chain fatty acids in cultured fi­
broblasts from Zellweger patients and parents, and from controls, are 
given in Table I. A striking elevation of the very long chain fatty 
acids, especially of hexacosanoic acid (C26:0) (about 10 times), was 
found in the fibroblasts from the Zellweger patients. The proportion of 
C22:0 in CHR-S fibroblasts was decreased till 50% of the normal level, 
similar to the results of Rizzo et al (1984) in childhood ALD. If the 
levels of C26:0, C25:0 and C24:0 are related to those of C22:0, in all 
patients increased ratios are found. 
In a series of six parents of Zellweger patients the levels and ratios 
of very long chain fatty acids in fibroblasts were in the same range as 
in fibroblasts from normal individuals (Table I). 
Table II lists the results of the determination of the very long chain 
fatty acids in cultured amniotic fluid cells from three pregnancies not 
at risk for Zellweger syndrome or ALD. The levels of C24:0 and C25:0 
were similar to those in normal fibroblasts, whereas the C26:0 level was 
somewhat higher. Also the ratios of C24:0, C25:0 and C26:0 resp. as com­
pared with C22:0, appear somewhat higher than was found for normal fi­
broblasts. However in fibroblasts from Zellweger patients, especially 
the C26:0/C22:0 ratio, was still considerably higher than in normal am­
niotic fluid cells. 
143 
Table I: Very long chain fatty acids and ratios of C24:0/C22:0, C25:0/C22:0, and C26:0/C22:0 in cultured 
fibroblasts. * 
Zellweger patients 
B.v.M. 
B.R. 
T.B. 
N.v.d.E. 
M.S. 
J.S. 
Range 
Parents of Zellweger 
patients 
Father of N.v.d.E. 
Mother of N.v.d.E 
Father of M.d.R 
Mother of M.d.R 
Father of B.R. 
Mother of B.R. 
Range 
Controls (N=4) 
Range 
C22:0 
0.79* 
0.74 
0.97 
0.80 
0.51 
0.97 
0.51-0.97 
1.3 
1.1 
1.6 
1.5 
1.6 
1.4 
1.1-1.6 
1.0-1.5 
C24:0 
2.1 
1.7 
2.0 
1.5 
1.6 
1.7 
1.5-2.1 
2.2 
1.5 
2.2 
2.5 
2.2 
2.2 
1.5-2.5 
1.5-2.3 
C25:0 
0.24 
0.13 
0.16 
0.12 
0.12 
0.17 
0.12-0.24 
0.068 
0.076 
0.105 
0.073 
0.055 
0.067 
0.055-0.105 
0.050-0.159 
C26:0 
0.44 
0.31 
0.47 
0.33 
0.37 
0.33 
0.31-0.47 
0.044 
0.030 
0.038 
0.024 
0.029 
0.049 
0.024-0.049 
0.030-0.067 
C24:0/C22:0 
2.62 
2.31 
2.08 
1.86 
3.02 
1.81 
1.81-3.02 
1.69 
1.35 
1.34 
1.67 
1.37 
1.54 
1.34-1.69 
1.16-1.79 
C25:0/C22:0 
0.30 
0.17 
0.16 
0.15 
0.24 
0.18 
0.15-0.30 
0.051 
0.067 
0.065 
0.050 
0.034 
0.047 
0.034-0.067 
0.036-0.150 
C26:0/C22:0 
0.55 
0.42 
0.49 
0.42 
0.72 
0.34 
0.34-0.72 
0.033 
0.027 
0.023 
0.016 
0.018 
0.034 
0.016-0.033 
0.023-0.065 
л ' ' 1. . - • • 
* Values are expressed as % of total fatty acids (C14:0-C26:0). 
Table II: Very long chain fatty acids and ratios of C24:0/C22:0, C25:0/C22:0, and C26:0/C22:0 
in cultured amniotic fluid cells. * 
normal amniotic 
fluid cells 
1 
2 
3 
normal fibroblasts 
(n=4) 
Range 
C22:0 
0.61* 
0.85 
0.64 
1.0-1.5 
C24:0 
2.3 
2.3 
1.9 
1.5-2.3 
C25:0 
0.090 
0.120 
0.085 
0.050-0.159 
C26:0 
0.115 
0.107 
0.047 
0.030-0.067 
C24:0/C22:0 
3.79 
2.71 
3.05 
1.16-1.79 
C25:0 / C22:0 
0.146 
0.142 
0.134 
0.036-0.150 
C26:0 / C22:0 
0.188 
0.126 
0.074 
0.023 - 0.065 
* Values are expressed as % of total fatty acids (C14:0-C26:0). 
DISCUSSION 
The elevated level of the C26:0 fatty acid in fibroblasts, brain white 
matter and adrenal gland of Zellweger patients as previously described 
by Brown et al (1982) and also established in serum (Bakkeren et al, 
1984), indicates once again the involvement of the peroxisomal deficien-
cy in the biochemical disturbances in this syndrome. Very long chain 
fatty acids are preferably degraded by the peroxisomal ß-oxidation sys-
tem (Kawamura et al, 1981). In childhood ALD the accumulation of very 
long chain fatty acids in fibroblasts could be related to an impaired 
peroxisomal oxidation of these substances (Singh et al, 1984). Partin 
and McAdams (1983) reported absence of peroxisomes in the liver of neo-
natal ALD. 
Until now three biochemical abnormalities have been found in fibroblasts 
from CHR-S patients. Besides the abnormal very long chain fatty acid 
pattern established by Brown et al (1982), an increased sensitivity of 
Zellweger fibroblasts to antimycin A (Kelley et al, 1983) has been re-
ported. CHR-S heterozygote fibroblasts however were not investigated by 
these authors. Recently Heymans et al (1984) showed that fibroblasts of 
Zellweger patients contain a lower ethanolamine plasmalogen fraction 
compared to controls. Heterozygotes and controls were not different. 
The slightly higher level of C26:0 in normal amniocytes compared with 
normal fibroblasts was already mentioned by Moser et al (1982) and 
remains unexplained. 
In Zellweger syndrome the heterozygous parents did not show an elevation 
of the very long chain fatty acid levels neither in serum (Bakkeren et 
al 1984) nor in fibroblasts. This fact indicates that this technique can 
be applicated for the prenatal diagnosis of Zellweger syndrome. 
In a comparable study on the autosomal recessive neonatal onset form of 
ALD Jaffe et al (1982) also did not find increased very long chain fatty 
acid levels in fibroblasts and plasma from the parents of two patients. 
In the X-linked form of ALD an increased content of very long chain 
fatty acids has been found in plasma (Moser A et al, 1980) and fibro-
blasts (Kawamura et al, 1978, Moser H et al, 1980B, Rizzo et al 1984). 
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For 80% of the obligate heterozygotes the C26:0/C22:0 ratio in fibro-
blasts was more than 2 SD in excess of the control mean (Moser et al, 
1980A, O'Neill et al, 1982, Tönshoff et al, 1982, Moser H et al, 1983). 
This increased ratio can be explained by selection favouring the mutant 
allele (Migeon et al, 1981). 
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CHAPTER VII 
PIPECOLIC ACID LEVELS IN SERUM AND URINE 
FROM NEONATES AND NORMAL INFANTS; 
COMPARISON WITH VALUES REPORTED 
IN ZELLWEGER SYNDROME 
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ABSTRACT 
Pipecolic acid (PA) excretion from normal neonates, prematures and/or 
small for dates has been determined and correlated with gestational age, 
sex and age after birth. 
Sex influence was not detectable. 
Only small for dates with a gestational age of > 34-37 weeks had a lower 
urinary excretion of PA than the appropriate for dates with the same ge-
stational age. Preterm infants had a higher excretion of PA than term 
neonates. PA excretion of infants decreases with age after birth. This 
higher excretion in "younger" infants can be explained by a higher serum 
concentration and less efficient tubular reabsorption. 
PA level in serum and urine remains a valuable tool for the confirmation 
of the clinical diagnosis of Zellweger syndrome when gestational age and 
age after birth are taken into consideration. 
No PA was detected in serum or urine of four children suffering from hy-
perthyroidism. 
KEY WORDS 
Pipecolic acid - prematurity - cerebro-hepato-renal syndrome of Zellwe-
ger - hyperthyroidism. 
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INTRODUCTION 
Pipecolic acid (PA), a metabolite of lysine, was found in the urine of 
young infants and neonates (Woody et al, 1970). One of four infants less 
than 1 year old, two of four term neonates and four of four prematures 
excreted PA in the urine. PA was not found in urine of four children 
over 1 year of age (Woody et al, 1970). No serum PA levels were repor-
ted in that study. 
Children with hyperlysinemia due to defective functioning of the lysine-
saccharopine-a-aminoadipic acid pathway, excreted increased concentra-
tion of PA in urine. Woody et al (1970) thus suggested a reduced lysine-
a-ketoglutarate reductase activity in neonates as an explanation for PA 
excretion in urine. Hutzler and Dancis (1983) found sligthly elevated 
plasma levels of PA in newborn infants, compared with older infants. 
Pipecolic aciduria with increased serum levels is one of the various 
biochemical abnormalities in the cerebro-hepato-renal syndrome of 
Zellweger (Danks et al, 1975, Trijbels et al, 1979, Govaerts et al, 
1982), and in hyperpipecolatemia (Gatfield et al, 1968, Thomas et al, 
1975, Arneson et al, 1982). Pipecolic aciduria was also reported in 
hyperthyroidism (Sonada et al, 1957) and in kwashiorkor (Schendel et al, 
1959, Whitehead et al, 1964). 
The aim of this study is to present values for PA excretion in urine and 
serum levels of preterm infants, term neonates and infants during the 
first year of life, with a more sensitive method than used by Woody et 
al (1970). These values will be compared with those published in the 
cerebro-hepato-renal syndrome of Zellweger, where the PA levels remain a 
valuable diagnostic tool. 
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PATIENTS AND METHODS 
Patients 
From 224 children (149 boys and 75 girls) 357 24-h collections of urine 
were analysed. Each urine specimen was emptied into a sterile collection 
bottle as soon as it was passed and was kept at 4<,C. At the end of the 
24-h period, the urine was frozen and stored at -20oC until analysis. 
Infants delivered before 37 weeks from the first day of the last men­
strual period were classified preterra (W.H.O.). They were subdivided in 
three groups: 26-30 weeks, >30-34 weeks, >34-37 weeks of gestation. 
Small for dates infants had a birth weight <P3 according to the data of 
Kloosterman (1969). 
Serum levels (114 samples) were measured from 50 children (21 girls and 
29 boys). The samples were drawn in the morning (8 a.m.), and stored at 
-20oC until analysis. 
All infants were considered to be normal, without renal- or liver dis­
orders. 
Four children with hyperthyroidism due to autoimmune thyroiditis were 
also tested, as increased values were described in literature (Sonada et 
al, 1957). 
Informed consent was obtained from the parents. 
Methods 
PA was determined by ion-exchange chromatography on an amino acid analy­
ser (Biotronik LC 2000 or LC 6000) according to a procedure given by the 
manufacturer. To increase the sensitivity of the method the ninhydrin 
reagent was prepared in the following way: one volume of methylcello-
solve was mixed with 3 volumes of glacial acetic acid. After bubbling 
oxygen-free nitrogen through this mixture (at least 30 min), ninhydrin 
(20 g/1) was added and bubbling of nitrogen was continued until ninhy­
drin was dissolved. No reducing reagent was used. To increase the reac­
tion time with ninhydrin the reaction coil (internal diameter 0.3 mm) 
was replaced by a coil with an internal diameter of 0.55 mm. 
Serum samples of 0.5 ml were required. The detection limit is 3 |ЛЮІ/1. 
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The PA excretion is expressed as ymol/g creatinine. As the collection of 
24 h urine samples from young children is notoriously prone to error, 
the concentrations expressed in vimol/g creatinine and ymol/kg/24 h were 
correlated from the collections of the boys. The regression coefficients 
of the different gestational age groups were 26-30 w: r= 0.877; >30-34w: 
r= 0.827; >34-37w: r= 0.763; >37w: r= 0.787 with a p-value =0.001 in 
each group of neonates (praol/kg/24 h on the y-axis and pmol/g creatinine 
on the x-axis). We concluded that the generally used unit ymol/g creati-
nine is reliable. Further results are given in pmol/g creatinine. 
As it is assumed that proline, hydroxyproline, glycine and PA share a 
common renal transport mechanism, the concentration of these compounds 
was determined by ion exchange chromatography in the urine collections 
with high and low value of PA. 
The statistical analysis of the PA levels was performed according to 
Koziol et al, 1981, with the Kruskal-Wallis test and with Spearman 
correlation coefficients in order to determine the significance of the 
different items. Values of normal infants were compared with those of 
Zellweger syndrome patients by the Wilcoxon 2 sample test. 
RESULTS 
I URINE 
Significance of the different items in neonates and infants: 
Sex: 
There was no significant sex difference of the PA levels in urine in the 
different gestational age groups of neonates. The distribution-free test 
according to Koziol et al (1981) for the four gestational age groups re-
sulted in a p-value >0.1. 
The item "sex" was then omitted in the further statistical analysis. 
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Small for dates: 
Some influence of dysmaturity in the different groups of gestational age 
was noted. The small for dates (N=12) with a gestational age of>34-37 w 
had significantly lower levels of PA in urine than the appropiate for 
dates neonates with the same gestational age (N=43) (P <0.01 with the 
distribution free-test according to Koziol et al, 1969). Irrespective of 
the gestational age of the newborns no significant difference in PA ex­
cretion between appropiate for dates (N=241) and small for dates (N=81) 
was found with the distribution-free test according to Koziol et al, 
1969. 
Gestational age: 
The PA concentration in urine at several ages of the different gestatio­
nal age groups is presented in Table I. The PA excretion determined at 
the same age after birth, decreases when the gestational age increases 
(p <0.01 with the Kruskal-Wallis test). 
Age after birth: 
The influence of the age after birth on the median PA level in urine of 
the different gestational age groups is also shown in Table I. No diffe­
rence in the urinary PA level of the prematures of different gestational 
ages when they have reached the at term age was seen. 
The PA excretion of infants delivered after a fullterm pregnancy decrea­
ses with age (Fig. 1). The Spearman correlation coefficient for age is 
-0.27304 with ρ <0.01 (N=112). 
The concentrations of PA, proline, hydroxyprollne and glycine are shown 
in Table II. As expected, at low urinary PA levels, low proline, hydro­
xyprollne and glycine excretion was found. 
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Table I: The number of determinations (Ν), the range, and the median 
level (M) of urinary PA excretion (ymol/g creatinine). 
Age 
after birth 
1 d 
4 d 
8 d 
2 w 
4 w 
6 w 
8 w 
10 w 
N 
range 
M 
N 
range 
M 
N 
range 
M 
N 
range 
M 
N 
range 
M 
N 
range 
M 
N 
range 
M 
N 
range 
M 
Gestational age 
26-30 w 
8 
42-392 
142.5 
10 
24-360 
158.5 
13 
23-651 
135 
13 
49-1285 
255 
12 
61-1330 
191 
14 
46-393 
204 
9 
53-450 
107 
5 
21-113 
73 
>30-34 w 
12 
27-254 
111.5 
25 
22-290 
88 
28 
30-255 
78 
19 
20-229 
57 
14 
19-270 
75 
9 
18-298 
78 
• I 
>34-37 w 
7 
31-93 
51 
16 
25-202 
56 
17 
27-246 
73 
10 
25-216 
67.5 
4 
30-130 
103.5 
>37 w 
22 
2.6-119 
13.5 
23 
7-94 
26 
18 
13-243 
27 
10 
13-54 
37 
4 
18-37 
31.5 
d = day(s) 
w = week(s) 
Comparison of urinary pipecolic acid levels between normal neonates and 
patients with the Zellweger syndrome: 
When the lowest PA excretion of 14 patients suffering from the Zellweger 
syndrome (as reported by Govaerts et al, 1982) were compared with the 
highest PA excretion of neonates with a gestational age of >37w, a sig­
nificant difference was found (p-value»0.0001 with the Wilcoxon 2-sample 
test). 
Fig. 1: The pipecolic acid excretion of term infants during infancy 
(N=118). 
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TABLE II: The excretion of hydroxyprollne, proline and glycine in 24 h 
urine collections with high and low concentration of PA 
(pmol/g creatinine). 
low PA N 
Range 
Median 
Mean 
S.D 
high PA N 
Range 
Median 
Mean 
S.D. 
Pipecolic 
acid (PA) 
8 
3-25 
11.5 
12.9 
7.4 
8 
303-1330 
444.5 
650 
420 
Hydroxy-
proline 
8 
25-4526 
446 
1017 
1498 
8 
2626-11729 
6025 
6067 
3209 
Proline 
8 
91-5341 
295.5 
1078 
1820 
8 
2098-13904 
5628 
6293 
3661 
Glycine 
8 
966-13631 
2572.5 
4323 
4519 
8 
10728-46113 
19946 
22163 
12551 
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II SERUM 
Pipecolic acid concentration in serum of neonates: 
The PA level in serum of prematures with a gestational age of 26-30 w is 
given in Fig. 2. An age dependency in PA serum levels is clear. The 
great number of sera with a PA concentration below the detection limit 
made a statistical analysis of these data unreliable. 
Fifty seven determinations of PA in serum from children with a gestatio­
nal age of > 30 weeks were performed: only twice a level above 3 pmol/l 
was found (in the group with a gestational age of >30-34 w: 4.6 pmol/l 
and 3.5 ixmol/l respectively). When these prematures reached the at term 
age no PA could be determined in serum. 
Fig. 2: The pipecolic acid level in serum of preterm infants with a ge­
stational age of 26-30 w (N=59). 
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Comparison of pipecolic acid concentration in serum of normal infants 
and children with the Zellweger syndrome: 
Comparison of the levels of PA in serum of 10 Zellweger patients and 
normal neonates resulted in a p-value<0.01 (Wilcoxon 2-sample test) for 
every group of neonates and at every age after birth. 
Ill HYPERTHYROIDISM 
In four new patients with hyperthyroidism (age between 9 and 13 years) 
no PA was detectable neither in serum nor in urine. Some relevant infor-
mation about their thyroid function at the time of urine collection and 
blood sampling is given in Table III. 
TABLE III: Thyroid function of four children with hyperthyroidism due 
to autoimmune thyroiditis before treatment. 
Initials 
K.d.M. 
F.G.Z. 
E.T. 
M.L. 
Normal values 
Age 
(years) 
13 
13 
97/12 
13 
h 
(nmol/1) 
252 
395 
244 
345 
50-130 
T3 
(ng/100 ml) 
598 
600 
400 
400 
85-185 
TSH 
(uE/ml) 
7.1 
4.2 
< 2.0 
< 2.0 
< 2-8 
T, = thyroxin 
T, = triidothyronine 
TSH = thyroid stimulating hormone 
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DISCUSSION 
The urinary excretion of PA is increased in preterm neonates compared 
with term neonates, and in normal neonates compared with older infants. 
This increased excretion of PA is due either to elevated filtered load 
exceeding the reabsorptive capacity or to a maturation of the reabsorp­
tion in kidney-tubule cell. 
An elevated serum level of PA contributes to the increased urinary ex­
cretion of PA. Preterm infants have a higher serum level of PA than 
term neonates. Our measured values for PA are slightly lower than those 
reported by Hutzler and Dancis (1983). These authors reported a mean 
plasma concentration of 2.1 μηοΐ/l ± 1.6 (SD) in their pediatric popula­
tion (aged 4 months to 17 years). During the first week of life a mean 
value of 12 ymol/l ±5.1 was calculated (N=9). Their gestational age was 
not reported. In liver disease a normal, marginally or distinctly eleva­
ted value was found. The increase of serum PA at younger age can be ex­
plained by an increased flux of lysine through the PA pathway or by a 
decreased catabolism of PA. Recent studies in our laboratory have demon­
strated that PA is metabolized via the peroxisomes in rat liver (Trij-
bels et al, in preparation). This might explain the increased PA serum 
level and the increased excretion of PA in Zellweger syndrome, a disease 
characterized by the absence of peroxisomes in liver and kidney tissue 
(Goldfischer et al, 1973). A development of several peroxisomal funtions 
has been observed in different mammals (Masters and Holmes, 1977). An 
increase of PA catabolism with age owing to this maturation of peroxiso­
mal functions is an acceptable hypothesis for the decrease of serum PA 
level with age. 
On the basis of genetic studies in man two modes of transport for the 
iminoacids (L-proline, 4-hydroxy-L-proline) and glycine are proposed 
(Scriver, 1968, Lasley and Scriver, 1979). A common system with high 
capacity and higher affinity for imino acids than for glycine is lack­
ing in familial renal iminoglycinuria. Two additional systems, each 
with low capacity, are proposed. One of those systems is shared by pro­
line and hydroxyproline, the other system has a preference for glycine. 
The immaturity of the reabsorption of imino acids and glycine during 
infancy has been well studied (Brodehl, 1978). Hyperiminoaciduria sub-
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sides during the first three months of life while hyperglycinuria per-
sists for about six months in the normal infant. If PA is transported by 
the iminoglycine transport system, decreased reabsorption during the 
first months of life is expected. Support for this hypothesis can be 
given by the concordant changes in the excretion of imino acids, glycine 
and PA (Table II). Ganapathy et al, 1983, studied the transport of 
proline and PA in purified brush border membrane vesicles from rabbit 
renal cortex. PA transport was completely inhibited by proline and 
hydroxyproline and moderate inhibition was observed with glycine. It was 
concluded that proline and PA share a common transport system in the 
rabbit kidney. 
In one patient with hyperthyroidism, Sonoda (1957) showed the probable 
presence of PA in urine by paperchromatography. We were unable to con-
firm his findings in 4 children with hyperthyroidism using a more sensi-
tive and specific technique. 
When gestational age and age after birth are taken into consideration, 
the PA level in serum and urine remains a valuable tool for the confir-
mation of the clinical diagnosis of Zellweger syndrome. 
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CHAPTER Vili 
GENERAL CONSIDERATIONS 
It is evident that all biochemical abnormalities observed in CHR-S 
should be related to the absence or near absence of peroxisomes. For 
most of the biochemical disorders an acceptable explanation can be of-
fered. In what way the clinical symptoms of CHR-S are induced by this 
variety of defects, remains a challenge for all investigators involved 
in this field. 
MORPHOLOGIC EVIDENCE FOR THE ROLE OF PEROXISOMES IN THE CNS AND THE EYES 
McKenna et al (1976) reported catalase positive microperoxisomes in the 
spinal cord neurons, oligodendrocytes, ependymal cells lining the fourth 
ventricle, astrocytes and Schwann cells of the CNS of the adult rat. 
Neurons of catecholaminergic brain regions and sympathetic ganglia of 
the rat contain appreciable numbers of microperoxisomes, but the majori-
ty of neurons of other regions contain few bodies with demonstrable ca-
talase activity. In dorsal root ganglia only occasional neurons contain 
appreciable numbers of microperoxisomes (Citkowitz et al, 1973, McKenna 
et al, 1976). An age-dependent distribution of D-amino acid oxidase-po-
sitive and catalase-positive microperoxisomes in rat brain was described 
by Weimar and Neims (1977) and Arnold and Holtzman (1978). In early 
postnatal CNS of the rat catalase-positive microperoxisomes were found 
in all cell types in all regions studied. During the first three postna-
tal weeks catalase-positive bodies were seen in synaptic terminals in 
several areas, a location where they are seldom observed in mature tis-
sue. The varying distribution of these organelles in developing nervous 
tissue, together with their presence in regions which have few micro-
peroxisomes in the adult rat, suggest that their functions may differ 
somewhat in immature and adult nervous tissue (Arnold and Holtzman, 
1978). In all regions studied microperoxisomes were found in oligoden-
drocyte processes immediately adjacent to the outer lamellae of forming 
myelin sheaths (Arnold and Holtzman, 1978, Holtzman, 1982). 
Microperoxisomes were found to be abundant in the retinal pigment epi-
thelium of the human, the rhesus monkey and rodents by ultrastructural 
histochemistry (Leuenberger and Novikoff, 1975, Robison and Kuwabara, 
1975). They were rare in other cells of the retina and choroid (Robi-
son and Kuwabara, 1975). 
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An extensive DAB-positive tubular system was seen in the synaptic termi­
nals of the photoreceptor cells in rodents (Leuenberger and Novikoff, 
1975). Histopathologic studies of the retina of patients suffering from 
CHR-S revealed abnormal clumps of pigment epithelial cells in the peri­
phery (Volpe and Adams, 1972) and an unmistakable loss of photoreceptor 
cells affecting mainly the rods (Garner et al, 1982) in the outer seg­
ments of the mldperiphery. No studies concerning (micro-)peroxisomes in 
these cells in Zellweger syndrome are reported. This particular locali­
zation of the peroxisomes are in favour of an important metabolic role 
of the peroxisomes in the eye. 
In this paper we will further discuss the main biochemical abnormalities 
seen in CHR-S and speculate about the basic defect. In serum and fibro­
blasts of ALD almost the same aberrant very long fatty acid pattern is 
seen as in CHR-S. This fact justifies a separate discussion in this 
chapter. 
PATHOGENESIS OF BIOCHEMICAL DISORDERS AND ITS CLINICAL SIGNIFICANCE 
Catabolism of pipecollc acid 
The role of the peroxisomes in PA catabolism in rats was recently inves­
tigated in our laboratory. Peroxisomes were isolated by Percoli density 
14 
gradient centrifugation of rat liver homogenate. The C0„ production 
rate was measured in the different fractions after incubation with 
[ 14 1 14 
1- СI PA. The peak of the CO. production rate was located in those 
fractions showing the highest activity of catalase and urate-oxidase, 
the well-known peroxisomal markers. These experiments indicate that PA 
catabolism in rat liver is located in peroxisomes. When these findings 
can be applied to man, the increased concentration of PA in serum, urine 
and CSF in CHR-S is easily understood. 
L-PA is a normal constituent of mammalian brain and a major product of 
L-lysine metabolism in the brain. PA has been shown to have a role in 
the nervous system function. Intraventricular administration of 500 yg 
of PA produces ptosis, hypotonia, sedation and hypothermia in mice (Ta-
kahama et al, 1982). Administration into the cerebellum and hippocampus 
of cats with chronically· implanted cannulae and electrodes caused promi­
nent depression both in EEG and behaviour (Kasé et al, 1980). 
171 
PA has been found to inhibit the uptake of H GABA into brain slices 
and also facilitate the release of this compound from the slices. The 
uptake of PA in glial cell fractions and synaptosomes is inhibited by 
GABA and vice-versa. Using unit recording and micro-electrophoretic 
technique Kasé et al (1980) demonstrated a depression of the firing of 
cortical neurons by PA. These findings suggest that PA is involved in 
the regulation of synaptic mechanism in the CNS (Charles et al, 1983) 
by affecting the GABA-ergic transmission i.e. by inhibiting the uptake 
of endogenous GABA and/or by facilitating the release of the inhibitory 
transmitter. In the CSF of two of our patients suffering from CHR-S, 
normal concentration of GABA was measured. 
Biosynthesis in vitro of I HI piperidine from D, L Ι H I PA was very low 
in brain and kidney. No other organs showed any formation of H pipe­
ridine (Nomura et al, 1983). They questioned the hypothesis of a metabo­
lic activity of piperidine in brain. 
Pathogenesis of liver dysfunction 
Pedersen and Gustafsson (1980) and Kasé et al (1983) showed that the 
peroxisomal fraction of rat liver homogenate is able to catalyse the 
conversion of THCA into cholic acid. Hanson et al (1977) investigated 
the influence of an intravenous infusion of tauro-THCA on hepatic mor-
phology in rats. Liver biopsy sections from rats infused for 2h showed 
dilatation of the rough ER and distortion of the mitochondrial membra-
nes. Chronic exposure of the liver to tauro-THCA was not tested. This 
study suggests that the increased level of THCA could be responsible for 
the liver damage in Zellweger syndrome (Hanson et al, 1977, Monnens et 
al, 1980, Mathis et al, 1980). 
Deficiency of plasmalogens 
Plasmalogens are ubiquitous membrane constituents in mammals. According 
to Hajra and Bishop (1982) peroxisomes may supply the lipid precursors 
acyl-DHAP or alkyl-DHAP to ER for lipid synthesis and provide some kind 
of substrate level control system for cellular membrane biogenesis. 
Recent findings of Declercq et al (1984) support their hypothesis. Per-
oxisomes are not equipped with all enzymes needed for the synthesis of 
complex ether lipids. The enzymes choline phosphotransferase, ethanola-
mine phosphotransferase, catalyzing the terminal reactions in the syn-
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thesis of complex ether lipids, are absent from peroxisomes. The almost 
complete absence of plasraalogen-phosphatidylethanolamine and plasraalo-
gen-phosphatidylcholine in several tissues of CHR-S (Heymans et al, 
1984) suggests the possibility of a disturbance of membrane function in 
CHR-S. Such an abnormal membrane composition could interfere with e.g. 
the activity of mitochondrial-membrane-bound enzymes such as succinate-
ubiquinone oxidoreductase and the cholesterol side-chain cleavage enzyme 
of the adrenal cortex (Simpson and Waterman, 1983). As ethanolamine 
plasmalogen is the most important phospholipid component of human myelin 
with a changing composition during development (Boggs and Rangarag, 
1984), dysmyelination, observed in the CNS of CHR-S, is an expected fin-
ding. 
Increased saturated very long chain fatty acid levels 
In CHR-S the same abnormalities of VLCFA were observed as in ALD. ALD is 
a disorder biochemically characterized by increased levels of saturated 
VLCFA in serum, cultured skin fibroblasts, erythrocyte membranes (Tsuji 
et al, 1981, Kobayashi et al, 1983, Knazek. et al, 1983), leucocytes 
(Molzer et al, 1981) and in cholesterolesters of the brain white matter 
(Brown et al, 1983). 
One of the apparent effects of this fatty acid accumulation is to in-
crease the index of microviscosity (Knazek et al, 1983). Measurements of 
fluorescence polarization demonstrated a highly significant increase in 
the microviscosity of erythrocyte membranes in ALD (Knazek et al, 1983). 
Experimental data in animals point to a correlation between membrane 
viscosity and the number of hormone receptors in target tissues. There-
fore Knazek et al (1983) proposed that the decrease in responsiveness to 
ACTH in ALD is secondary to increased membrane viscosity of the adrenal 
gland cells. On the basis of the same arguments a disturbed thyroid 
function could be predicted (Bashford et al, 1975). Investigation of the 
basal levels of T,, T,, and TSH in 5 patients with CHR-S revealed how-
ever normal values (unpublished results). Studies about the insulin re-
ceptors are in progress. 
Alteration of the lipid fluidity of ER membranes can modify the activity 
of steroid biosynthetic enzymes (21-hydroxysteroid hydroxylase and 3-
B-hydroxysteroid dehydrogenase) (De Paillerets et al, 1984) and in this 
way influence the action of ACTH. 
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Increased VLCFA in brain gangliosides (Igarashi et al, 1976) and In mye-
lin fractions of brain white matter from patients with ALD (Brown et al, 
1983) were observed. The same biochemical abnormalities are probably 
present also in CHR-S. 
BASIC DEFECT IN CHR-S 
The absence of peroxisomes in liver and kidney tissue of CHR-S allows 
only one hypothesis related to the basis defect: an abnormality in the 
biogenesis or maintenance of the peroxisomal membrane. In every paper 
published about CHR-S during recent years the dysfunction of the peroxi-
somes is proposed as the primary defect. Already in 1979 Pfeifer and 
Sandhage expressed their view In this way: "The term peroxisome defi-
ciency is proposed as a name which probably is more closely related to 
the pathogenetic mechanism than the hitherto usual designation cerebro-
hepato-renal syndrome." 
Although morphologic studies suggest that the membrane of a peroxisome 
arises from a protusion of the ER, the polypeptide composition of the 
peroxisomal membranes is very different from that of the ER or mitochon-
drial membranes. Particularly noteworthy is the absence of cytochrome 
P450, the most abundant ER membrane protein in peroxisomal membranes 
(Lazarow, 1982). 
The biogenesis of the peroxisomal membrane itself is at the present time 
unclear. Analogous with other Inborn errors of metabolism one enzyme 
deficiency should exist leading to a defective synthesis of the peroxi-
somal membrane. The consequences for the activity of the different en-
zymes normally present inside the peroxisomes can be predicted. Peroxi-
somal proteins are synthesized on free polysomes, at their mature size 
rather than as large precursors, and enter peroxisomes without proteo-
lytic processing. One of the enzymes studied by MIura et al (1984), 
however, appears to be translated as a large precursor which is proteo-
lytically processed to form the mature enzyme. It is not sure that the 
proteolytic processing is linked with transport into the peroxisome. 
When we accept a normal formation of the peroxisomal proteins on the 
free ribosomes in CHR-S, it is quite possible to observe a lowered en-
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zymatic activity in vitro and in vivo. It is possible that some of the­
se proteins remain in the precursor form, and lack normal activity. 
Without "protection" by the peroxisomal membrane catabolism in the cyto­
plasm could be raised. Finally, and this could be important in vivo, the 
enzymatic activity is not concentrated and well assembled in peroxiso­
mes. 
RELATION BETWEEN CHR-S AND THE NEONATAL FORM OF ALD 
Clinical features 
Neonatal ALD (McKusick 20237) was first described by Ulrich et al, 1978. 
Dysmorphic features were first mentioned by Benke et al, 1981, who noti­
ced clinical similarities with the CHR-S. It should be noted that adre­
nal insufficiency wasn't clinically apparent in neonatal ALD (Jaffe et 
al, 1982, Brown et al, 1982) while biochemically evident adrenocortical 
hypofunction was demonstrated by ATCH stimulation test (Jaffe et al, 
1982). The lack of affected individuals in relatives of the mother and 
the equal severity in both male and female patients suggest autosomal 
recessive transmission (Benke et al, 1981) in contrast with the X-linked 
childhood ALD (Table I). 
Biochemical data 
Biochemical analysis of the serum, fibroblasts, and tissues from pa­
tients with neonatal ALD and CHR-S revealed increased levels of satura­
ted VLCFA, already known to occur in childhood ALD (Manz et al, 1980, 
Jaffe et al, 1982, Brown et al, 1982, МоЫеу et al, 1982, Haas et al, 
1982, Bakkeren et al, 1984). The increased level of С , in plasma 
(Moser et al, 1983, Moser et al, 1984) and in cultured skin fibroblasts 
(Björkhem et al, 1984, Moser et al, 1984) of CHR-S patients is described 
in cultured skin fibroblasts in neonatal ALD (Moser et al, 1983). 
Investigation of the adrenal function in CHR-S revealed a primary adre-
nocortical insufficiency (see Chapter V ) , one of the conspicious fea-
tures of ALD. In childhood ALD normal PA levels in plasma were reported 
(Moser et al, 1984). Analysis of the bile acid pattern and plasmalogens 
in patients suffering from the neonatal form of ALD is required. 
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Pathologie studies 
Absence of hepatic peroxisomes in neonatal ALD was reported by Partin 
and McAdams (1983), while normal peroxisomes were noted in childhood ALD 
(Moser et al, 1984). Unusual appearing liver mitochondria and lysosomal 
lamellar crystalline inclusions in hepatocytes and liver macrophages 
were reported in neonatal ALD (Partin and McAdams, 1983). Striated 
lamellar bodies, typical for ALD, sometimes surrounded by a single mem-
brane, were seen in macrophages of brain, liver, thymus and lyniphnodes, 
in glial cells, adrenocortical cells and hepatocytes in neonatal ALD 
(Partin and McAdams, 1983, Haas et al, 1982, Ulrich et al, 1978). 
A few authors mentioned similar abnormalities in ALD and CHR-S. Agamano-
lis et al, 1976, noticed a similarity between the cytoplasmic inclusions 
(multilamellar bodies) of macrophages, Oligodendroglia! cells and astro-
cytes of the CNS of Zellweger patients and the inclusions seen in the 
adrenals, Schwann cells, testis and brain of patients with childhood 
ALD. The lamellar-lipid profiles, considered to be diagnostic for ALD 
(childhood and neonatal form), were found by Goldfischer et al (1983) in 
the adrenal glands of 7 patients with CHR-S. Ocular histopathologic and 
biochemical studies demonstrated that the CHR-S and the neonatal ALD are 
similar with regard to ocular abnormalities and the presence of satura-
ted VLCFA (Cohen et al, 1983). 
Only one out of four patients with neonatal ALD showed cortical cysts in 
the kidneys. 
Conclusion 
Neonatal ALD and CHR-S are probably two designations of the same condi-
tion. The clinical and biochemical abnormalities of childhood ALD are 
more restricted, and point to another peroxisomal dysfunction; possibly 
a single peroxisomal enzyme deficiency (Brown et al, 1982, Moser et al 
1984). 
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TABLE I: Review of relevant data of CHR-S, neonatal ALD and childhood 
ALD. 
CLINICAL ASPECTS 
mode of inheritance 
dysmorphisms 
age of onset 
age at death 
adrenal insufficiency 
BIOCHEMICAL FINDINGS 
hyperpipecolic acidemia 
increased THCA 
plasmalogens deficiency 
increased VLCFA:-saturated 
-
 C26:l 
ULTRASTRUCTURAL FINDINGS 
peroxisomes 
CHR-S 
autosomal 
recessive 
+ 
at birth 
usually 
infancy 
+ 
+ 
+ 
+ 
+ 
+ 
absent 
Neonatal ALD 
autosomal 
recessive 
+ 
at birth 
infancy 
or childhood 
+ 
9 
7 
? 
+ 
+ 
absent 
Childhood ALD 
X-linked 
-
childhood 
adulthood 
+ 
? 
? 
-
+ 
7 
normal 
+ = present 
- = absent 
? = unknown 
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ANTENATAL DIAGNOSIS OF CHR-S 
The abnormal VLCFA pattern in cultured amnlocytes allowed identification 
on three affected fetuses out of 9 pregnancies (Moser et al, 1984). It 
is a convenient technique for prenatal detection of CHR-S. 
The deficiency of plasmalogens and deficiency of acyl-Coa:DHAP acyl-
transferase offer another possibility for prenatal diagnosis. 
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SUMMARY 
In the first chapter of this thesis a review is given of the present 
knowledge about peroxisomes in mammals and man. This is required to ful-
ly understand the Investigations reported in the other chapters. The li-
terature about clinical, biochemical and pathologic features of the ce-
rebro-hepato-renal (Zellweger) syndrome is summarized in chapter II. 
The CHR-S is an autosomal recessive inherited disorder, with characte-
ristic dysmorphisms (high forehead, frontal bossing, large fontanels, 
epicanthal folds, abnormal ears). It included severe neurological dys-
function (severe hypotonia, poor sucking, seizures, absent reflexes, 
severe psychomotor retardation, severe hearing impairment), ocular symp-
toms (nystagmus, cloudy cornea, lenticular opacities, optic disc pallor 
and peripheral clumping of pigment), hepatomegaly and failure to thrive. 
Ninety percent of the patients die before one year of age. Peroxisomes 
are absent or nearly absent in liver, kidney and brain. 
The following relevant biochemical abnormalities are observed: decreased 
catabolism of pipecolic acid, defect of bile acid synthesis with increa-
sed concentration of THCA and DHCA in bile, serum and urine, increased 
urinary excretion of p-OH-phenyllactate, abnormal pattern of very long 
chain fatty acids in serum and cultured fibroblasts, deficiency of plas-
malogens, and mitochondrial disturbance (Chapter II and III). 
A neurophysiological study of eleven patients revealed diffuse dysfunc-
tion of the cerebrum and myelinated fiber tracts. The EEC's showed 
characteristic continuous negative sharp waves and spikes at the vertex 
(Chapter IV). 
The striking resemblance of CHR-S and the neonatal form of ALD prompted 
us to investigate the adrenocortical function in CHR-S as this function 
is disturbed in adrenoleukodystrophy. A primary adrenocortical insuffi-
ciency could be demonstrated. This insufficiency might contribute to the 
unexpected death of infants with CHR-S (Chapter V). 
An increased level of very long chain fatty acid was measured in cul-
tured skin fibroblasts. This method is applied for prenatal diagnosis by 
Moser et al (1984) (Chapter VI). 
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Pipecolic acid (PA) excretion in urine from normal neonates, preterm in-
fants and/or small for dates has been determined and correlated with ge-
stational age, sex and after birth (Chapter VII). Preterm infants had a 
higher excretion of PA than normal neonates. PA excretion decreases with 
age after birth. The PA level in serum and urine remains a valuable tool 
for the confirmation of the clinical diagnosis of CHR-S when gestational 
age and age after birth are taken into consideration. 
Analogous with other inborn errors of metabolism one enzymatic deficien-
cy should exist leading to a defective synthesis of the peroxisomal mem-
brane. This primary deficiency will lead to secondary deficiencies of 
some enzymes normally located in the peroxisomes. 
Neonatal adrenoleukodystrophy and CHR-S are probably two designations 
of the same condition (Chapter VIII). 
A prenatal diagnosis of CHR-S is feasible. 
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SAMENVATTING 
Het eerste hoofdstuk geeft een overzicht van de huidige kennis van per-
oxisomen in zoogdieren en in de mens. Deze kennis is noodzakelijk om de 
biochemische en klinische afwijkingen in het Zellweger syndroom, een 
ziektebeeld gekenmerkt door een peroxisomendeficiëntie, te begrijpen. 
Het CHR-S is een autosomaal recessief overervend ziektebeeld waarvan de 
incidentie geschat wordt op 1/100 000 levend geborenen. 
Een overzicht van de klinische symptomen, radiologische en electrofysio-
logische afwijkingen, pathologische anatomie en biochemische afwijkin-
gen, gebaseerd op 96 in de literatuur beschreven patiënten en 16 eigen 
patiënten, wordt weergegeven in hoofdstuk II, III en IV. 
De meest voorkomende symptomen zijn: dysmorfieën (te wijde fontanellen, 
hoog gewelfd voorhoofd, epicanthus, abnormale oorschelpvorm en -inplan-
ting, pes equinovarus en dwarse handlijnen), ernstige hypotonie en psy-
chomotorische retardatie, convulsles, hyporeflexie tot areflexie, hepa-
tomegalie, gehoorsverlies van 70 dB en oogafwijkingen (nystagmus, cornea 
en lenstroebeling, bleke papillen en beeld van tapetoretinale degenera-
tie). Er is tactiel kontakt (ze reageren adekwaat op strelen en op pijn-
prikkels). Ondanks voldoende kalorieën-intake (meestal via sondevoeding) 
groeien deze kinderen slecht. Negentig procent van de patiënten over-
lijdt gedurende het eerste levensjaar, meestal t.g.v. een pneumonie of 
ze worden onverwacht dood in bed gevonden. 
Het Zellweger syndroom wordt gekarakteriseerd door de volgende bioche-
mische afwijkingen: gestoorde leverfunktie (soms met bloedingsneiging), 
abnormale galzuursamenstelling (aanwezigheid van de precursors THCA en 
DHCA) in gal, serum en urine, verhoogde pipecolinezuurspiegel in serum, 
urine en liquor, verhoogde excretie van p-OH-fenylmelkzuur in urine, 
verhoogde concentratie van de verzadigde zeer lange ( > C22) vetzuren en 
van C26:l in serum en gekweekte fibroblasten, plasmalogenendeficiëntie 
in weefsels, erythrocyten en fibroblasten, deficiëntie van acyl-CoA:DHAP 
acyltransferase in lever, hersenen en fibroblasten, defect in de ademha-
lingsketen en een deficiëntie tot afwezigheid van peroxisomen in lever-, 
hersen- en nierweefsel. 
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Het neurofysiologisch onderzoek (EEG, BAEP en SSEP) van elf patiënten 
met het Zellweger syndroom (hoofdstuk IV) leverde diffuus ernstig ge-
stoorde registraties op, wijzend op grijze en witte stof aantasting. 
Vanwege de klinische (dysmorfieën en neurologisch beeld), biochemische 
(verhoogde concentratie van verzadigde zeer lange vetzuren in serum en 
fibroblasten) en anatomopathologische (E.M. van de bijnieren en de ogen) 
overeenkomsten met de neonatale vorm van ALD hebben we een ACTH stimula-
tietest uitgevoerd bij 6 patiënten met het Zellweger syndroom, en drie 
kontroles van vergelijkbare leeftijd (hoofdstuk V). De patiënten hebben 
een primaire bijnierschorsinsufficiëntie, welke waarschijnlijk een rol 
speelt in de onverwachte dood. Vergelijking van alle beschikbare gege-
vens van kinderen met neonatale ALD en Zellweger syndroom wijst erop dat 
het hoogstwaarschijnlijk om hetzelfde ziektebeeld gaat dat onder twee 
verschillende beschrijvingen en namen in de literatuur bekend is. 
In hoofdstuk VI worden de gehaltes aan zeer lange vetzuren in gekweekte 
fibroblasten van Zellwegerpatienten, obligate dragers en gezonde kon-
troles en in normale gekweekte amnioncellen weergegeven. Antenatale 
diagnostiek op basis van deze bepaling in vruchtwater en gekweekte am-
nioncellen is mogelijk indien de ouders dit wensen. De verschillende mo-
gelijkheden voor prenatale diagnostiek worden aangegeven in hoofdstuk 
VIII. 
Pipecolinezuur, een afbraakprodukt van lysine, is bij Zellwegerpatienten 
en gezonde prematuren verhoogd in urine en serum. Het normale pipecoli-
nezuurgehalte in urine en serum van gezonde prematuren en zuigelingen 
tot 1 jaar is bepaald (hoofdstuk VII). Er is een significant verschil 
tussen de pipecolinezuurconcentraties van normale pasgeborenen en zuige-
lingen enerzijds en van Zellweger patiënten anderzijds. 
De (mogelijke) Pathogenese van de verschillende klinische en biochemi-
sche afwijkingen van het Zellweger syndroom wordt uitvoerig toegelicht 
in hoofdstuk VIII. Het basisdefect is gelegen in een stoornis in de bio-
genesis van de peroxisomale membraan. 
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SAMENVATTING VOOR DE LEEK 
De samenvatting van dit proefschrift bevat veel "vaktermen", zodat U 
waarschijnlijk bij woorden als "peroxisomen", "dysmorfieën" en "primaire 
bijnierschorsinsufficiëntie" de draad verliest. Om die reden wordt deze 
korte toelichting over de inhoud van dit proefschrift gegeven. 
Het "cerebro-hepato-renaal syndroom van Zellweger" is een erfelijk ziek-
tebeeld. Beide ouders zijn drager van het afwijkende erfelijke mate-
riaal. Zij hebben geen klachten en weten dan ook niet dat ze drager zijn 
tot de diagnose Zellweger syndroom bij hun kind gesteld wordt. Bij iede-
re zwangerschap bestaat een risico van 25% op een kind met het syndroom. 
De kinderen hebben uitwendig zichtbare aangeboren afwijkingen (hoog 
voorhoofd, te laag ingeplante en abnormaal gevormde oorschelpen, afwij-
kende handlijnen en soms klompvoetjes) en tekenen van hersenbeschadig-
ing (te zwakke spieren, stuipen, abnormale reflexen, slecht drinken, 
ernstige ontwikkelingsachterstand, slecht gehoor- en gezichtsvermogen). 
Ze reageren wel op aanraken, lachen bij op schoot zitten, huilen en ver-
tonen een afweerreactie bij pijn en laten duidelijk blijken wanneer ze 
schik hebben. De lever is vergroot en werkt matig; dit kan aanleiding 
geven tot stollingsstoornissen (vlug blauwe plekken). 
Negentig procent van deze patientjes overlijdt in het eerste levensjaar; 
meestal worden ze onverwacht dood in bed gevonden of overlijden ze 
ten gevolge van een gewone verkoudheid. 
Bij laboratoriumonderzoek zijn er vele afwijkingen in bloed, urine, gal, 
hersenvocht en gekweekte huidcellen. Er zijn specifieke afwijkingen bij 
weefselonderzoek met de microscoop, vooral in de hersenen, de lever en 
de nieren. Ze hebben geen last van deze microscopische nierafwijkingen. 
Een overzicht van deze afwijkingen bij 96 kinderen beschreven in de vak-
literatuur en 16 patiënten van onze kliniek is weergegeven in hoofdstuk 
II en III. 
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Gezien de ernstige hersenaantasting zijn er meerdere onderzoeken ver-
richt om deze aantasting duidelijker te kunnen beschrijven. In hoofdstuk 
IV staan de resultaten van deze technische onderzoeken. Er is een ern-
stige algemene aantasting van de verschillende meetbare hersenfunkties. 
Het Zellweger syndroom lijkt, zowel klinisch als biochemisch, op een 
ander erfelijk ziektebeeld, namelijk "neonatale ALD". Dit laatste 
syndroom wordt tevens gekenmerkt door een slechte bijnierfunktie. In 
hoofdstuk V worden de resultaten van het bijnierfunktie-onderzoek van 6 
kinderen met het Zellweger syndroom weergegeven. Ook deze kinderen 
hebben een onvoldoende reactie van de bijnier. Deze bijnierfunktie is 
nodig in stress-situaties zoals diarree, koorts, luchtweginfekties. De-
ze verminderde bijnierfunktie speelt waarschijnlijk een rol bij de 
plotselinge dood van de Zellweger patientjes. Bij stress-situaties kan 
men met medicijnen deze onvoldoende bijnierfunktie opvangen. Een uitvoe-
rige vergelijking van alle gegevens van het Zellweger syndroom en de 
neonatale ALD (hoofdstuk VIII) geeft aanwijzingen dat het waarschijnlijk 
eenzelfde ziektebeeld is dat onder twee verschillende namen in de lite-
ratuur beschreven is. 
De biochemische afwijkingen in gekweekte huidcellen bieden de mogelijk-
heid, wanneer de ouders dit wensen, tijdens een eventuele volgende 
zwangerschap te bepalen of het kindje de ziekte heeft. Dit wordt afzon-
derlijk besproken in hoofdstuk VIII. 
Een van de vele biochemische afwijkingen in het Zellweger syndroom is 
een gestoorde afbraak van pipecolinezuur. Deze stof is verhoogd in 
bloed, urine en hersenvocht. Normale, te vroeg geboren kinderen, kunnen 
ook een hoge waarde van pipecolinezuur hebben in serum en urine. Van 
vele te vroeg geboren kinderen is pipecolinezuur in de urine en in het 
bloed gemeten. Deze uitslagen liggen lager dan de uitslagen van de pa-
tienten met Zellweger syndroom (hoofdstuk VII) zodat de meting van het 
pipecolinezuur voor de diagnose bij een pasgeborene verdacht van 
Zellweger syndroom zinvol blijft. 
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De oorzaak van het Zellweger syndroom is een tekort (en misschien zelfs 
een ontbreken) van peroxisomen. In (bijna) alle cellen van zoogdieren en 
mensen zitten peroxisomen. In deze peroxisomen vinden vele scheikundige 
reacties plaats (hoofdstuk I). De argumenten om de structurele en bio-
chemische afwijkingen te verklaren op basis van het tekort aan peroxi-
somen worden genoemd in hoofdstuk VIII. 
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I 
De kinderen met de diagnose "Infantile phytanic acid storage disease, 
a possible variant of Refsum's disease" vertonen meer gelijkenis met 
het syndroom van Zellweger dan met de ziekte van Refsum. 
Scotto et al: J Inker Metab Dis 5, 83-90, 1982 
II 
Analoog aan de bevindingen bij adrenoleukodystrofie kan een func-
tionele stoornis van de testosteronesynthese bij het syndroom van 
Zellweger worden verwacht. 
Griffin et al: Neurology 27: 1107-1113, 1977 
III 
Toediening van indocid in combinatie met hydrochlorothiazide is 
vooral bij zuigelingen en jonge kinderen met nefrogene diabetes in-
sipidus aan te bevelen. 
Monnens et al: Clinical Science 66: 709-715, 1984 
IV 
In tegenstelling met de bevindingen vermeld door Tina et al is de 
excretie van hydroxylysylglycosiden bij het syndroom van Alport 
normaal. 
Tina et al: Pediat Res 13: 774-776, 1979 
Schröder et al: Abstract, Interni Ped Nephrol 5: 112, 1984 
V 
De benaming "Martin-Bell syndrome" verdient de voorkeur boven 
"fragile X syndrome". 
Sherman et al: Ann Hum Genet 48: 21-37, 1984 
VI 
Prenatale diagnostiek is eerder curatieve dan preventieve geneeskunde. 
VII 
Moleculaire diagnostiek bij "inborn errors of metabolism" vereist 
ervaring op een specifiek gebied. Centralisatie van de moleculaire 
diagnostiek is dus een vereiste. 
VIII 
Het invoeren van een verplichte (maximaal) veertigurige werkweek 
(in dienstverband) voor het personeel in de gezondheidszorg zou de 
tewerkstelling en de gezondheid van het personeel ten goede komen, 
en hoogstwaarschijnlijk ook de gezondheidszorg van de patiënten. 
IX 
De aanhef "Cher Monsieur" of "Dear Sir" op overdrukaanvraag-
kaartjes is verouderd. "Chère Collègue, Cher Collègue" of "Dear Col-
league" zijn goede alternatieven. 
Χ 
Het wél of niet getrouwd zijn, of plannen daartoe hebben, is voor de 
"werkgever" tijdens een sollicitatiegesprek met een vrouwelijke (kin-
der-)arts blijkbaar belangrijker dan haar medisch-ethisch denken. 
Lutgarde C.P. Govaerts 29 november 1984 



